Alzheimer’s disease (Late onset), excluding more controls

AD_LO_EXMORE

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data
1. Apply sex-specific rule None	-
2. Check conditions None
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — F00.1, F00.10, F00.10G30.1, G30.1, G30.1+F00.10 Cause of death:* ICD-10 — F00.1, F00.10, F00.10*G30.1, G30.1, G30.1+F00.10 2 out of 7 registries used, show all original rules.	-
4. Check minimum number of events None	-
5. Include endpoints None	-
6. Filter based on genotype QC (FinnGen only) None	-

Control definitions (FinnGen only)

Control exclude: G6_AD_WIDE, F5_DEMENTIA, F5_DEMENTIA_U, F5_PSYCH, NEURODIS, MEMLOSS, TRAUMBRAIN_NONCONCUS

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	AD_LO_EXMORE
CONTROL_EXCLUDE	G6_AD_WIDE\|F5_DEMENTIA\|F5_DEMENTIA_U\|F5_PSYCH\|NEURODIS\|MEMLOSS\|TRAUMBRAIN_NONCONCUS
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	F001\|G301
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	F001\|G301
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Alzheimer’s disease (Late onset), excluding more controls based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Alzheimer’s disease (Late onset)

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	155025	100212	53777
Only index persons	132407	86940	45467
Unadjusted period prevalence (%)
Whole population	2.38	2.87	1.50
Only index persons	2.69	3.20	1.74
Median age at first event (years)
Whole population	82.51	83.17	81.33
Only index persons	82.80	83.44	81.58

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	9974	4828	5146
Unadjusted period prevalence (%)	1.97	1.65	2.27
Median age at first event (years)	80.66	80.70	80.61

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2762: Matched controls
24158

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

N06DA03

ATC

rivastigmine; oral, transdermal

1546.2

323.0

857

N05AX08

ATC

risperidone; systemic

136.1

323.0

646

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

923.0

323.0

585

N06DX01

ATC

memantine; oral

1678.8

323.0

1653

G30.1

ICD-10 Finland

Alzheimer disease with late onset

1415.4

323.0

2206

N06DA02

ATC

donepezil; oral

1055.0

323.0

1565

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

29.1

323.0

996

458

P20

ICPC

Memory disturbance

20.4

323.0

1491

1313

F00.10*G30.1

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

541.3

323.0

951

F00.10

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

+∞

323.0

450

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

+∞

323.0

706

N05AH04

ATC

quetiapine; oral

16.2

323.0

568

379

F03

ICD-10 Finland

Unspecified dementia

85.3

323.0

450

AA1AD

NOMESCO Finland

CT of head and brain

7.3

323.0

940

1585

SPAT1053

SPAT

Memory test

6.6

323.0

1317

2942

N06DA04

ATC

galantamine; oral

471.2

323.0

334

A28

ICPC

Limited function/disability NOS

6.6

299.2

924

1711

P70

ICPC

Dementia

167.4

295.8

322

R41.3

ICD-10 Finland

Other amnesia

61.2

277.9

339

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

158.7

253.9

278

F06.7

ICD-10 Finland

Mild cognitive disorder

48.7

249.7

317

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

185.3

231.6

251

G30

ICD-10 Finland

Alzheimer disease

535.4

219.2

226

TAB00

NOMESCO Finland

Lumbar puncture

29.1

205.7

293

G47.3

ICD-10 Finland

Sleep apnoea

18.6

196.7

322

170

G30.8

ICD-10 Finland

Other Alzheimer disease

182.2

195.1

212

R53

ICD-10 Finland

Malaise and fatigue

4.7

187.7

761

1797

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

8.1

185.7

460

578

S06.0

ICD-10 Finland

Concussion

24.0

179.0

269

108

SPAT1245

SPAT

Provision of support and information to patient’s family members

12.0

174.0

343

282

N06AX11

ATC

mirtazapine; oral

3.8

170.8

928

2842

SPAT1216

SPAT

Assessment of functional ability

4.2

169.9

777

2039

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

+∞

168.1

168

N03AG01

ATC

valproic acid; systemic, rectal

73.7

164.8

196

G30.0

ICD-10 Finland

Alzheimer disease with early onset

779.7

164.0

168

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

11.5

162.9

327

278

SPAT1234

SPAT

Support of social functional capacity

12.5

160.6

309

240

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

4.7

158.0

631

1436

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

+∞

153.9

154

N05BA04

ATC

oxazepam; oral

3.8

150.2

780

2258

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

32.4

144.6

200

XA800

NOMESCO Finland

Neuropsychological investigation

69.7

143.5

172

F32.9

ICD-10 Finland

Depressive episode, unspecified

20.4

143.1

226

105

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

9.0

136.5

313

338

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

3.1

136.5

989

3654

N05AH03

ATC

olanzapine; systemic

50.3

133.2

168

N06AB10

ATC

escitalopram; oral

5.4

125.4

419

768

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

16.9

124.6

210

117

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

4.7

124.1

484

1051

N06AB04

ATC

citalopram; systemic

4.0

123.4

572

1467

N06AX26

ATC

vortioxetine; oral

23.2

115.8

175

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

+∞

115.6

116

SPAT1222

SPAT

Counselling/guidance promoting independent living

3.6

114.6

628

1845

F00.00*G30.0

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms

+∞

114.6

115

G40.9

ICD-10 Finland

Epilepsy, unspecified

359.8

113.3

119

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

517.6

109.9

114

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

8.1

108.1

262

307

A04

ICPC

Weakness/tiredness general

3.9

100.8

471

1198

R41.0

ICD-10 Finland

Disorientation, unspecified

19.1

97.7

157

L28

ICPC

Limited function/disability (L)

3.3

97.6

596

1875

F00.20*G30.8

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

36.5

95.4

128

I67.3

ICD-10 Finland

Progressive vascular leukoencephalopathy

83.4

94.0

110

SPAT1254

SPAT

Administration of medicine

3.4

93.9

532

1578

R42

ICD-10 Finland

Dizziness and giddiness

2.8

89.8

713

2660

G56.0

ICD-10 Finland

Carpal tunnel syndrome

10.0

86.4

184

171

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

210.0

86.2

F05.9

ICD-10 Finland

Delirium, unspecified

166.2

83.9

F00.9

ICD-10 Finland

Dementia in Alzheimer disease, unspecified

381.0

81.0

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

727.6

78.6

WYA20

NOMESCO Finland

Home visit

30.3

78.6

110

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

681.3

73.7

A06AD11

ATC

lactulose; oral

3.0

72.3

480

1569

N05BA06

ATC

lorazepam; systemic, sublingual

6.5

70.9

199

286

F05.1

ICD-10 Finland

Delirium superimposed on dementia

+∞

69.5

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

23.0

69.0

104

F0019, G301

ICD-10 Finland

+∞

68.5

Z01.9

ICD-10 Finland

Special examination, unspecified

4.4

65.6

263

569

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

+∞

65.5

R56.8

ICD-10 Finland

Other and unspecified convulsions

11.6

65.2

128

101

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

+∞

64.5

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

22.5

64.0

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

107.6

63.4

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.3

63.3

740

3315

N06AB06

ATC

sertraline; oral

4.9

61.2

217

413

N06AX21

ATC

duloxetine; oral

4.8

60.5

218

422

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

4.7

60.1

220

433

ACC51

NOMESCO Finland

Release of median nerve

54.5

58.9

SPAT1229

SPAT

Assessment of need for aid

3.7

57.1

279

719

G20

ICD-10 Finland

Parkinson disease

57.0

56.9

F29

ICD-10 Finland

Unspecified nonorganic psychosis

140.7

56.8

U04

ICPC

Incontinence urine

4.8

56.8

204

393

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

28.7

56.7

110

Kela drug reimbursment

Parkinson's disease and comparable movement disrorders

+∞

56.6

N06AX16

ATC

venlafaxine; oral

4.5

55.0

209

427

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

506.8

54.8

R55

ICD-10 Finland

Syncope and collapse

2.9

53.9

377

1258

N03AX14

ATC

levetiracetam; systemic

35.8

53.8

SPAT1246

SPAT

Screening of depression or other psychiatric problem

10.2

53.7

112

100

SPAT1172

SPAT

Guidance concerning hydration

9.6

52.9

114

108

K90

ICPC

Stroke/cerebrovascular accident

52.8

52.3

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.6

52.1

431

1590

F00.20

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

129.3

52.0

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

479.4

51.9

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

246.0

51.5

SPAT1101

SPAT

Orthostatic test

4.2

50.5

208

459

N05AD01

ATC

haloperidol; systemic

9.1

50.0

111

AXX01

SPAT

8.6

49.9

114

120

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

10.5

49.8

102

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

7.9

48.6

117

134

F00.00

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms

+∞

48.6

SPAT1360

SPAT

Extensive global examination

3.0

48.5

308

961

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

231.8

48.5

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

+∞

47.6

N05AB03

ATC

perphenazine; systemic, rectal

21.1

47.5

I95.1

ICD-10 Finland

Orthostatic hypotension

5.6

46.5

144

234

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

26.0

46.4

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

115.7

46.2

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

4.4

45.7

179

376

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

4.3

45.4

179

379

F00

ICD-10 Finland

Dementia in Alzheimer disease

415.8

45.0

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.5

44.8

401

1538

W19

ICD-10 Finland

Unspecified fall

3.1

44.3

264

786

S01.0

ICD-10 Finland

Open wound of scalp

3.5

44.1

223

588

F34.1

ICD-10 Finland

Dysthymia

48.1

42.8

N03AF02

ATC

oxcarbazepine; oral

23.4

42.4

N02BE01

ATC

paracetamol; systemic, rectal

2.0

42.4

2342

17681

AAD10

NOMESCO Finland

Evacuation of chronic subdural haematoma

388.7

42.0

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

+∞

41.6

Z02.4

ICD-10 Finland

Examination for driving licence

0.5

41.4

509

7330

I61.9

ICD-10 Finland

Intracerebral haemorrhage, unspecified

+∞

40.6

I61.0

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, subcortical

+∞

40.6

R51.80

ICD-10 Finland

Headache

3.0

39.9

252

781

F22.0

ICD-10 Finland

Delusional disorder

130.1

39.5

F21

ICPC

32.1

39.5

F00.14

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms of mixed type

361.5

39.1

N29

ICPC

Neurological sympt/complt other

12.8

37.4

N03AF01

ATC

carbamazepine; oral, rectal

5.9

37.4

110

168

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.3

37.0

398

1664

Z02.7

ICD-10 Finland

Issue of medical certificate

3.6

37.0

181

464

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

+∞

36.7

F001, G301

ICD-10 Finland

+∞

36.7

SPAT1252

SPAT

Overall medication plan or its review

2.8

36.4

255

843

F32

ICD-10 Finland

Depressive episode

7.5

36.0

107

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.4

35.4

343

1360

G44.2

ICD-10 Finland

Tension-type headache

3.3

34.9

194

546

C10AA01

ATC

simvastatin; oral

1.7

34.9

1515

10223

3540A

ICD-9 Finland

Mononeuritis of upper limb and mononeuritis multiplex, Carpal tunnel syndrome

+∞

34.7

SPAT1304

SPAT

Counselling and guidance related to ageing

2.4

34.5

316

1216

A29

ICPC

General symptom/complaint other

2.3

34.5

353

1438

N30.0

ICD-10 Finland

Acute cystitis

2.2

34.2

378

1595

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

316.4

34.1

Z75.5

ICD-10 Finland

Holiday relief care

53.2

34.0

N06AA09

ATC

amitriptyline; systemic

2.8

34.0

235

770

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

3.1

34.0

207

622

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

4.6

33.8

125

248

S06.3

ICD-10 Finland

Focal brain injury

+∞

33.7

G72.8

ICD-10 Finland

Other specified myopathies

+∞

33.7

N17

ICPC

Vertigo/dizziness

2.3

33.1

344

1410

N05AA02

ATC

levomepromazine; systemic

9.3

32.9

R5140

NOMESCO Finland

Monitoring the use of the aid

3.7

32.7

150

364

N06AB03

ATC

fluoxetine; oral

2.7

32.6

243

833

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

13.2

32.0

N03AE01

ATC

clonazepam; systemic

4.7

32.0

114

218

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.6

31.7

261

948

F01.9

ICD-10 Finland

Vascular dementia, unspecified

40.3

31.6

R41

ICD-10 Finland

Other symptoms and signs involving cognitive functions and awareness

13.4

31.6

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

7.4

31.5

SPAT1301

SPAT

No procedures

1.7

30.9

918

5514

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

39.3

30.7

3472A

ICD-9 Finland

Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]

+∞

30.7

N05AD03

ATC

melperone; systemic

26.0

30.7

P29

ICPC

Psychological sympt/compl other

7.5

30.6

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

5.7

30.6

145

N04AA02

ATC

biperiden; systemic

145.8

30.0

N05CD07

ATC

temazepam; oral

2.3

30.0

312

1277

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.6

29.9

231

808

N02AA05

ATC

oxycodone; systemic

2.0

29.8

449

2154

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

8.2

29.8

N06AG02

ATC

moclobemide; oral

4.6

29.7

108

211

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

+∞

29.7

F0014, G301

ICD-10 Finland

+∞

29.7

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

276.0

29.2

WX780

NOMESCO Finland

Remote monitoring CPAP

141.3

29.0

IGY02

NOMESCO Finland

Psychiatric monitoring contact

+∞

28.7

N03AX09

ATC

lamotrigine; oral

20.5

28.7

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

2.2

28.5

305

1264

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

11.4

28.4

A06AC01

ATC

ispaghula (psylla seeds); oral

1.7

28.1

664

3707

N28

ICPC

Limited function/disability (N)

14.7

27.8

F01.20

ICD-10 Finland

Subcortical vascular dementia without additional symptoms

25.3

27.8

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

+∞

27.7

I61.1

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, cortical

+∞

27.7

F00.1

ICD-10 Finland

Dementia in Alzheimer disease with late onset

+∞

27.7

X59

ICD-10 Finland

Exposure to unspecified factor

2.0

27.5

400

1888

SPAT1139

SPAT

Nutrition survey

4.5

27.5

103

208

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.9

27.4

432

2101

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.3

27.2

286

1172

NFB20

NOMESCO Finland

Primary partial prosthetic replacement of hip joint using cement, other or unspecified

5.9

27.1

120

S72.0

ICD-10 Finland

Fracture of neck of femur

3.6

27.0

127

315

F01.2

ICD-10 Finland

Subcortical vascular dementia

38.7

26.9

F009, G309

ICD-10 Finland

+∞

26.7

85000

ICD-8 Finland

Concussion, Current or unspecified

+∞

26.7

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.4

26.7

238

899

SPAT1231

SPAT

Assessment of adjustments needed in living environment

7.6

26.5

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.1

26.4

329

1457

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

23.0

26.4

N05AX12

ATC

aripiprazole; systemic

248.2

26.3

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

128.0

26.1

R11

ICD-10 Finland

Nausea and vomiting

2.6

26.0

201

703

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

10.8

25.8

S06.6

ICD-10 Finland

Traumatic subarachnoid haemorrhage

+∞

25.7

F05.8

ICD-10 Finland

Other delirium

238.9

25.3

I60.9

ICD-10 Finland

Subarachnoid haemorrhage, unspecified

238.9

25.3

N03AX16

ATC

pregabalin; oral

1.8

25.2

479

2485

N05CF01

ATC

zopiclone; oral

1.6

25.1

775

4649

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.5

24.9

206

747

F10.20

ICD-10 Finland

Alcohol dependence currently independent

40.4

24.8

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

6.9

24.8

N27

ICPC

Fear of neurological disease other

6.4

24.7

G04BD12

ATC

mirabegron; oral

2.0

24.6

348

1622

N06AX03

ATC

mianserin; oral

3.9

24.4

104

238

F00.19

ICD-10 Finland

Dementia in Alzheimer's disease with late onset without information about additional symptoms

229.7

24.4

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

229.7

24.4

G45.4

ICD-10 Finland

Transient global amnesia

13.6

24.2

G31.0

ICD-10 Finland

Circumscribed brain atrophy

119.0

24.2

G25.9

ICD-10 Finland

Extrapyramidal and movement disorder, unspecified

39.1

23.9

G91.0

ICD-10 Finland

Communicating hydrocephalus

+∞

23.8

I69.0

ICD-10 Finland

Sequelae of subarachnoid haemorrhage

+∞

23.8

T36

ICD-10 Finland

Poisoning by systemic antibiotics

12.7

23.5

B01AC04

ATC

clopidogrel; oral

1.9

23.5

415

2097

K91

ICPC

Cerebrovascular disease

22.1

23.5

F99

ICD-10 Finland

Mental disorder, not otherwise specified

114.6

23.3

130

Kela drug reimbursment

Malignant tumour

0.4

23.1

1750

SPAT1307

SPAT

Psychosocial counselling and guidance

5.4

22.9

117

AAC00

NOMESCO Finland

Ligature of intracranial aneurysm

+∞

22.8

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

+∞

22.8

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

+∞

22.8

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

+∞

22.8

G91.9

ICD-10 Finland

Hydrocephalus, unspecified

+∞

22.8

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.5

22.7

193

710

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

2.3

22.6

234

951

SPAT1305

SPAT

Counselling and guidance related to physical exercise

2.1

22.6

262

1123

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

22.5

702

4201

F32.1

ICD-10 Finland

Moderate depressive episode

16.4

22.5

F00.11

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly paranoidism

211.4

22.4

NA1AD

NOMESCO Finland

Cervical spine CT examination

4.6

22.3

159

P03

ICPC

Feeling depressed

3.9

22.1

219

2402

FHL

External neurolysis of the nerve and possible alteration of the pathway (nerve pressure)

12.1

22.0

R51

ICD-10 Finland

Headache

4.0

21.8

200

F20.9

ICD-10 Finland

Schizophrenia, unspecified

+∞

21.8

30041

ICD-8 Finland

Neuroses, Depressiva

+∞

21.8

35399

ICD-8 Finland

Sciatica

+∞

21.8

R35

ICD-10 Finland

Polyuria

2.5

21.7

184

678

R25.1

ICD-10 Finland

Tremor, unspecified

4.9

21.6

133

R06.5

ICD-10 Finland

Mouth breathing

3.4

21.6

111

297

M48.0

ICD-10 Finland

Spinal stenosis

1.9

21.5

328

1570

F01.29

ICD-10 Finland

Subcortical vascular dementia without information on additional symptoms

202.5

21.4

PAF14

NOMESCO Finland

Thrombendarterectomy of internal carotid artery

202.5

21.4

H02AB02

ATC

dexamethasone; systemic

0.4

21.4

1983

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

3.2

21.4

116

323

WX723

NOMESCO Finland

CPAP therapy

73.5

21.4

N05AF03

ATC

chlorprothixene; systemic

17.7

21.3

E86

ICD-10 Finland

Volume depletion

5.0

21.3

124

Z29

ICPC

Social problem NOS

8.7

21.3

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

16.3

21.3

N18

ICPC

Paralysis/weakness

11.8

21.3

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

4.2

21.1

177

G04BD08

ATC

solifenacin; oral

2.2

21.1

217

881

SPAT1167

SPAT

Insertion of urinary catheter

3.2

20.8

113

315

I63.1

ICD-10 Finland

Cerebral infarction due to embolism of precerebral arteries

+∞

20.8

F0011, G301

ICD-10 Finland

+∞

20.8

AA5DR

NOMESCO Finland

Brain metabolism PET with CT

+∞

20.8

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

+∞

20.8

K59.0

ICD-10 Finland

Constipation

2.6

20.6

155

533

N05AC02

ATC

thioridazine; oral

21.0

20.6

A01

ICPC

Pain general/multiple sites

2.4

20.5

187

712

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

20.4

479

2638

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.0

20.4

126

383

F41.1

ICD-10 Finland

Generalized anxiety disorder

12.0

20.4

S70.0

ICD-10 Finland

Contusion of hip

3.7

20.4

222

N99

ICPC

Neurological disease other

25.6

20.4

C10AA05

ATC

atorvastatin; oral

1.5

20.3

1162

7955

P15

ICPC

Chronic alcohol abuse

12.6

20.3

J01EA01

ATC

trimethoprim; systemic

1.6

20.1

616

3654

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

38.2

20.1

N05AN01

ATC

lithium; oral

27.4

20.0

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.6

19.9

609

3608

F0009, G300

ICD-10 Finland

+∞

19.8

I63.5

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries

+∞

19.8

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

+∞

19.8

M54.5

ICD-10 Finland

Low back pain

1.6

19.7

634

3803

N87

ICPC

Parkinsonism

52.8

19.6

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

52.8

19.6

B01AC07

ATC

dipyridamole; systemic

3.4

19.6

257

G31.8

ICD-10 Finland

Other specified degenerative diseases of nervous system

184.8

19.5

T90.5

ICD-10 Finland

Sequelae of intracranial injury

96.8

19.4

SPAT1050

SPAT

Extensive neurological examination

4.7

19.3

130

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

19.2

409

2184

R4120

NOMESCO Finland

Occupational therapy

3.0

19.2

115

344

G43.9

ICD-10 Finland

Migraine, unspecified

13.1

19.0

G45.3

ICD-10 Finland

Amaurosis fugax

28.6

18.8

S06.2

ICD-10 Finland

Diffuse brain injury

+∞

18.8

I63.0

ICD-10 Finland

Cerebral infarction due to thrombosis of precerebral arteries

+∞

18.8

N05BA01

ATC

diazepam; systemic, rectal

2.0

18.8

257

1177

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

2.4

18.7

165

619

L89

ICD-10 Finland

Decubitus ulcer and pressure area

6.3

18.7

R32

ICD-10 Finland

Unspecified urinary incontinence

3.6

18.7

220

N05BE01

ATC

buspirone; oral

6.4

18.7

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.7

18.6

399

2135

A02BC03

ATC

lansoprazole; oral

1.5

18.4

689

4280

R1250

NOMESCO Finland

Evaluation of functional capability

5.5

18.3

C03CA01

ATC

furosemide; systemic

1.5

18.3

774

4941

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

40.5

18.0

A27

ICPC

Fear of other disease NOS

2.5

18.0

143

509

K59.09

ICD-10 Finland

Constipation, unspecified

2.3

17.9

166

640

P76

ICPC

Depressive disorder

4.9

17.9

109

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

+∞

17.8

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

+∞

17.8

G40

ICD-10 Finland

Epilepsy

+∞

17.8

N19

ICPC

Speech disorder

19.8

17.7

S00.0

ICD-10 Finland

Superficial injury of scalp

4.9

17.7

107

F10.09

ICD-10 Finland

Alcohol intoxication UNS

61.7

17.6

N06AX12

ATC

bupropion; oral

8.8

17.5

I67.9

ICD-10 Finland

Cerebrovascular disease, unspecified

88.0

17.5

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

17.5

366

1940

XF606

NOMESCO Finland

Ortostatic test

10.7

17.4

F10.25

ICD-10 Finland

Alcohol dependence continuous use

33.8

17.4

N05AL01

ATC

sulpiride; systemic

10.0

17.3

R63.4

ICD-10 Finland

Abnormal weight loss

2.9

17.3

111

349

N05AH02

ATC

clozapine; systemic

+∞

16.8

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

+∞

16.8

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

+∞

16.8

R33

ICD-10 Finland

Retention of urine

2.0

16.7

241

1127

J01CA08

ATC

pivmecillinam; oral

1.5

16.2

843

5595

A04AA02

ATC

granisetron; systemic, transdermal

0.3

16.1

1132

G72.9

ICD-10 Finland

Myopathy, unspecified

+∞

15.8

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

+∞

15.8

188

Kela drug reimbursment

Psychosis requiring demanding treatment

+∞

15.8

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

+∞

15.8

ZXA00

NOMESCO Finland

Right side

1.5

15.8

739

4792

IGY99

NOMESCO Finland

Other psychiatric treatment contact

55.6

15.7

P99

ICPC

Psychological disorders other

13.0

15.7

S20.2

ICD-10 Finland

Contusion of thorax

2.8

15.7

102

323

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

22.5

15.7

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

0.3

15.7

813

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.7

15.6

382

2118

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

149.4

15.6

N06AA06

ATC

trimipramine; systemic

4.7

15.5

103

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.8

15.5

277

1395

G47.9

ICD-10 Finland

Sleep disorder, unspecified

7.1

15.5

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

15.3

843

5637

SPAT1240

SPAT

Therapeutic discussion

2.6

15.2

112

381

G51.0

ICD-10 Finland

Bell palsy

11.1

15.2

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

17.6

15.2

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

3.5

15.2

183

R2110

NOMESCO Finland

Giving the first information

2.2

15.1

157

641

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.5

15.0

697

4501

N03AB02

ATC

phenytoin; systemic

13.5

14.9

F01.19

ICD-10 Finland

Multi-infarct dementia without information on additional symptoms

+∞

14.8

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

+∞

14.8

N01

ICPC

Headache

2.3

14.8

142

557

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

14.8

375

2097

E0000UV

ATC

1.4

14.8

882

5986

Z51.88

ICD-10 Finland

Other specified medical care

3.6

14.7

169

J01MA02

ATC

ciprofloxacin; systemic

1.4

14.7

970

6705

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

140.5

14.6

N05BA12

ATC

alprazolam; oral

2.1

14.5

171

736

R07.3

ICD-10 Finland

Other chest pain

1.9

14.5

218

1035

A23

ICPC

Risk factor NOS

2.5

14.4

118

428

G04BD04

ATC

oxybutynin; oral, transdermal

2.2

14.2

143

573

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.2

14.2

148

603

R13

ICD-10 Finland

Dysphagia

2.2

14.1

140

560

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

20.5

14.0

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.5

14.0

585

3691

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

15.6

14.0

SPAT1260

SPAT

Consultation of another employee

1.5

13.9

466

2798

I63

ICD-10 Finland

Cerebral infarction

49.8

13.9

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

+∞

13.8

2961C

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]

+∞

13.8

30040

ICD-8 Finland

Neuroses, Neurotico-depressiva

+∞

13.8

F05.0

ICD-10 Finland

Delirium not superimposed on dementia, so described

+∞

13.8

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

+∞

13.8

G81.9

ICD-10 Finland

Hemiplegia, unspecified

+∞

13.8

4340A

ICD-9 Finland

Occlusion of cerebral arteries, Cerebral thrombosis

+∞

13.8

D12

ICPC

Constipation

2.6

13.7

103

356

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

7.6

13.7

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.3

13.6

124

475

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

13.6

673

4390

P01

ICPC

Feeling anxious/nervous/tense

3.0

13.6

239

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.8

13.5

274

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

3.7

13.5

145

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

13.5

1106

7903

N03AX12

ATC

gabapentin; oral

1.7

13.5

269

1403

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

11.6

13.5

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

13.4

931

6460

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

4.3

13.4

103

N30.9

ICD-10 Finland

Cystitis, unspecified

2.3

13.4

127

495

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.9

13.4

201

953

S01.1

ICD-10 Finland

Open wound of eyelid and periocular area

3.6

13.3

152

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

13.3

656

4276

M79.6

ICD-10 Finland

Pain in limb

1.4

13.1

766

5150

A01AB09

ATC

miconazole; local oral

1.9

13.0

211

1026

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

3.3

13.0

178

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.9

13.0

192

906

AA1AD

SPAT

26.4

12.9

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

3.0

12.9

227

F00.13

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly depression

+∞

12.9

G99.2*M47.1

ICD-10 Finland

Spondylogenic compression of spinal cord

+∞

12.9

S06.9

ICD-10 Finland

Intracranial injury, unspecified

+∞

12.9

IAB14

NOMESCO Finland

Geriatric psychiatry consultation

+∞

12.9

N05AF05

ATC

zuclopenthixol; systemic

+∞

12.9

G41.9

ICD-10 Finland

Status epilepticus, unspecified

+∞

12.9

G31.1

ICD-10 Finland

Senile degeneration of brain, not elsewhere classified

+∞

12.9

P28

ICPC

Limited function/disability (P)

65.9

12.8

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

65.9

12.8

P05

ICPC

Senility, feeling/behaving old

15.4

12.8

SPAT1243

SPAT

Psychiatric/psychological examination

11.1

12.7

A05

ICPC

Feeling ill

2.6

12.7

330

C01DA14

ATC

isosorbide mononitrate; oral

1.5

12.6

432

2601

F10.24

ICD-10 Finland

Alcohol depence active use

29.9

12.6

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

29.9

12.6

I63.8

ICD-10 Finland

Other cerebral infarction

29.9

12.6

D11

ICPC

Diarrhoea

1.9

12.6

187

882

S22.3

ICD-10 Finland

Fracture of rib

2.2

12.6

135

560

R4130

NOMESCO Finland

Speech therapy

4.9

12.6

W10

ICD-10 Finland

Fall on and from stairs and steps

2.5

12.5

102

369

SPAT1236

SPAT

Informing family of child’s disability

3.0

12.4

213

U13

ICPC

Bladder symptom/complaint other

2.6

12.4

332

N06AX22

ATC

agomelatine; oral

14.2

12.4

WX722

NOMESCO Finland

PEEP

3.4

12.4

152

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.2

12.3

125

504

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.7

12.3

289

1581

N04BC05

ATC

pramipexole; oral

2.1

12.3

139

590

S01.8

ICD-10 Finland

Open wound of other parts of head

5.0

12.2

P06

ICPC

Sleep disturbance

2.1

12.1

136

575

L01BC06

ATC

capecitabine; oral

0.3

12.1

738

R52.9

ICD-10 Finland

Pain, unspecified

1.9

12.1

179

844

G45.8

ICD-10 Finland

Other transient cerebral ischaemic attacks and related syndromes

24.9

12.1

A10AE04

ATC

insulin glargine; parenteral

1.9

12.1

194

943

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

6.3

12.1

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.8

12.0

233

1205

G50.0

ICD-10 Finland

Trigeminal neuralgia

9.2

12.0

XA400

NOMESCO Finland

EEG

19.8

12.0

Z28

ICPC

Limited function/disability (Z)

19.8

12.0

R5110

SPAT

2.8

12.0

255

G25.0

ICD-10 Finland

Essential tremor

3.8

11.9

120

N06AX05

ATC

trazodone; oral

5.0

11.9

PAN14

NOMESCO Finland

Plastic repair of arteries internal carotid artery

+∞

11.9

F00.01

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms, mainly paranoidism

+∞

11.9

F31.8

ICD-10 Finland

Other bipolar affective disorders

+∞

11.9

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

+∞

11.9

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

+∞

11.9

F06.9

ICD-10 Finland

Unspecified mental disorder due to brain damage and dysfunction and to physical disease

+∞

11.9

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

+∞

11.9

F0024, G301

ICD-10 Finland

+∞

11.9

2961D

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN]

+∞

11.9

F32.0

ICD-10 Finland

Mild depressive episode

5.3

11.9

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

2.1

11.8

142

617

J01DB01

ATC

cefalexin; oral

1.4

11.8

1926

15192

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

114.1

11.8

AAF00

NOMESCO Finland

Ventriculostomy

114.1

11.8

I62.0

ICD-10 Finland

Nontraumatic subdural haemorrhage

114.1

11.8

E000001

ATC

1.5

11.7

401

2409

R00.1

ICD-10 Finland

Bradycardia, unspecified

2.4

11.7

100

371

B01AA03

ATC

warfarin; systemic

1.5

11.6

532

3404

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

0.3

11.6

810

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.4

11.6

594

3883

A02BC05

ATC

esomeprazole; systemic

1.4

11.6

891

6259

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.1

11.5

138

602

H53.1

ICD-10 Finland

Subjective visual disturbances

2.2

11.4

119

486

A02BC01

ATC

omeprazole; systemic

1.4

11.3

639

4252

SPAT1125

SPAT

Stoma care and guidance

3.6

11.3

126

PA7BD

NOMESCO Finland

CT angiography of neck and brain

6.9

11.3

N06AB08

ATC

fluvoxamine; oral

3.6

11.3

122

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

23.4

11.2

T08

ICPC

Weight loss

3.7

11.2

118

-2

ICPC

15.8

11.1

R47.1

ICD-10 Finland

Dysarthria and anarthria

15.8

11.1

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

15.8

11.1

SPAT1104

SPAT

Monitoring of emergency patient

1.9

11.1

160

748

EBA15

NOMESCO Finland

Extraction of large number of teeth

2.4

11.1

342

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.6

11.1

284

SPAT1263

SPAT

Sampling

1.3

11.1

1007

7246

N06AA04

ATC

clomipramine; systemic

5.5

11.0

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

10.9

1721

13408

N04BD01

ATC

selegiline; oral

57.0

10.9

IBZ07

NOMESCO Finland

Neurological assessment in psychiatry

+∞

10.9

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

+∞

10.9

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

+∞

10.9

2961E

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN+PSYKOOT PIIRTEI]

+∞

10.9

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

+∞

10.9

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

+∞

10.9

AAF15

NOMESCO Finland

Ventriculoatrial shunt

+∞

10.9

AA400

NOMESCO Finland

Electroconvulsive therapy

+∞

10.9

P72

ICPC

Schizophrenia

105.3

10.8

S09.9

ICD-10 Finland

Unspecified injury of head

6.1

10.8

G04BD07

ATC

tolterodine; oral

2.0

10.7

135

601

SPAT1276

SPAT

Outlining of treatment with patient or their family members

2.9

10.7

190

UKC02

NOMESCO Finland

Cystoscopy

1.5

10.6

453

2854

Y94.0

ICD-10 Finland

Accident at home

3.4

10.6

133

AA1CG

SPAT

7.8

10.6

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

7.3

10.6

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

10.6

371

2240

WX402

NOMESCO Finland

General anaesthesia

0.6

10.5

168

2360

SPAT1262

SPAT

Handing over of treatment supplies

1.5

10.5

456

2885

A46

ICD-10 Finland

Erysipelas

1.6

10.4

318

1857

R1250

SPAT

7.5

10.4

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

3.5

10.3

122

B03BA03

ATC

hydroxocobalamin; parenteral

1.9

10.3

155

736

H01BA02

ATC

desmopressin; nasal, systemic, sublingual

4.5

10.3

F22.9

ICD-10 Finland

Persistent delusional disorder, unspecified

38.0

10.2

F01.30

ICD-10 Finland

Mixed cortical and subcortical vascular dementia without additional symptoms

38.0

10.2

Z71.8

ICD-10 Finland

Other specified counselling

1.4

10.2

479

3071

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

10.1

904

6464

R99

ICD-10 Finland

Other ill-defined and unspecified causes of mortality

3.5

10.1

115

G04CA02

ATC

tamsulosin; oral

1.4

10.1

669

4562

G04BD09

ATC

trospium; oral

2.6

10.1

245

S42.2

ICD-10 Finland

Fracture of upper end of humerus

2.1

10.1

116

496

I50.9

ICD-10 Finland

Heart failure, unspecified

1.5

10.0

312

1833

AA1AA

NOMESCO Finland

Head X-ray examination

5.3

10.0

F43.29

ICD-10 Finland

Adaptation disorder UNS

24.6

10.0

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

52.6

10.0

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

13.6

10.0

Z73.6

ICD-10 Finland

Limitation of activities due to disability

5.1

10.0

N06AB05

ATC

paroxetine; oral

2.6

9.9

242

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

4.9

9.9

R47.8

ICD-10 Finland

Other and unspecified speech disturbances

10.4

9.9

3074A

ICD-9 Finland

Special symptoms or syndromes not elsewhere classified, Specific disorders of sleep of nonorganic origin[UNIHÄIRIÖ]

+∞

9.9

F00.09

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset information on additional symptoms is lacking

+∞

9.9

G21.9

ICD-10 Finland

Secondary parkinsonism, unspecified

+∞

9.9

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

+∞

9.9

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

+∞

9.9

F02.39*G20

ICD-10 Finland

Dementia in Parkinson's disease without information on additional symptoms

+∞

9.9

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

+∞

9.9

N03AX18

ATC

lacosamide; systemic

+∞

9.9

N05BA09

ATC

clobazam; oral

+∞

9.9

G91.1

ICD-10 Finland

Obstructive hydrocephalus

+∞

9.9

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

9.9

843

5982

L75

ICPC

Fracture: femur

3.9

9.9

A11

ICPC

Chest pain NOS

1.7

9.9

196

1021

Z60.8

ICD-10 Finland

Other problems related to social environment

96.5

9.8

R60.0

ICD-10 Finland

Localized oedema

1.6

9.8

255

1433

A02BA02

ATC

ranitidine; systemic

1.4

9.8

445

2834

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

1.7

9.8

217

1168

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

0.4

9.8

735

N05CD02

ATC

nitrazepam; oral

3.8

9.8

K59.1

ICD-10 Finland

Functional diarrhoea

2.1

9.7

112

482

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.7

9.7

208

1110

K08.3

ICD-10 Finland

Retained dental root

1.9

9.7

152

734

SPAT1138

SPAT

Guidance concerning bowel function

4.2

9.5

Z03

ICPC

Housing/neighbourhood problem

16.5

9.5

R44.3

ICD-10 Finland

Hallucinations, unspecified

16.5

9.5

S28

ICPC

Limited function/disability (S)

7.4

9.5

SPAT1224

SPAT

Implementation of speech therapy rehabilitation plan

5.9

9.5

N06AA12

ATC

doxepin; systemic

2.3

9.5

350

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

2.4

9.4

276

N06AA10

ATC

nortriptyline; systemic

4.5

9.4

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

9.4

547

3648

AA5PD

NOMESCO Finland

CT examination of brain pefusion

35.0

9.3

G04BD11

ATC

fesoterodine; oral

2.3

9.3

339

G45

ICD-10 Finland

Transient cerebral ischaemic attacks and related syndromes

11.5

9.3

G50.1

ICD-10 Finland

Atypical facial pain

6.7

9.3

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.3

9.3

1114

8276

KMAK

NOMESCO Finland

1.3

9.3

977

7132

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.7

9.3

177

910

G04CB01

ATC

finasteride; oral (testosterone-5-alpha reductase inhibitors)

1.5

9.2

327

1976

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

9.2

712

4968

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

9.2

269

1558

N05AA01

ATC

chlorpromazine; systemic, rectal

22.8

9.1

F80.1

ICD-10 Finland

Expressive language disorder

22.8

9.1

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

14.6

9.1

J01DA01

ATC

[U] cefalexin; systemic

1.3

9.1

1340

10221

M03BX01

ATC

baclofen; systemic

6.5

9.1

F01

ICD-10 Finland

Vascular dementia

17.5

9.1

Z13.3

ICD-10 Finland

Special screening examination for mental and behavioural disorders

48.2

9.1

I69.8

ICD-10 Finland

Sequelae of other and unspecified cerebrovascular diseases

48.2

9.1

R44.0

ICD-10 Finland

Auditory hallucinations

48.2

9.1

G56.2

ICD-10 Finland

Lesion of ulnar nerve

8.0

9.1

SPAT1285

SPAT

Provision of consultation response

1.9

9.0

131

616

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.6

8.9

269

1567

F00.12

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset, other additional symptoms, mainly hallucinations

+∞

8.9

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

+∞

8.9

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

+∞

8.9

G21.1

ICD-10 Finland

Other drug-induced secondary parkinsonism

+∞

8.9

G40.10

ICD-10 Finland

Simple partial seizures

+∞

8.9

LAITO

NOMESCO Finland

+∞

8.9

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

+∞

8.9

F60.9

ICD-10 Finland

Personality disorder, unspecified

+∞

8.9

F0012, G301

ICD-10 Finland

+∞

8.9

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

+∞

8.9

S01

ICD-10 Finland

Open wound of head

4.2

8.9

M03BX02

ATC

tizanidine; oral

1.3

8.8

1139

8528

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

4.6

8.8

R40.2

ICD-10 Finland

Coma, unspecified

7.6

8.8

S72.1

ICD-10 Finland

Pertrochanteric fracture

3.0

8.8

148

N80

ICPC

Head injury other

4.2

8.7

R60.9

ICD-10 Finland

Oedema, unspecified

2.0

8.7

106

466

EBA30

NOMESCO Finland

Excision of root of tooth

1.9

8.7

127

601

SPAT1281

SPAT

Other administrative function

1.7

8.7

188

1004

R25.2

ICD-10 Finland

Cramp and spasm

3.1

8.7

131

NF1AA

NOMESCO Finland

Hip X-ray examination

1.6

8.6

232

1315

M02AA07

ATC

piroxicam; topical

1.3

8.6

875

6339

I95.9

ICD-10 Finland

Hypotension, unspecified

4.0

8.6

A02BX02

ATC

sucralfate; oral

2.1

8.6

383

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.6

8.6

236

1345

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

8.6

676

4724

C07AA05

ATC

propranolol; systemic

1.5

8.5

298

1797

SPAT1251

SPAT

Organisation of medication

2.3

8.5

287

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.7

8.5

175

922

XA402

NOMESCO Finland

ENMG

4.0

8.5

Z20.8

ICD-10 Finland

Contact with and exposure to other communicable diseases

2.4

8.5

254

N43

ICPC

Neurological, Other diagnostic procedure

6.2

8.5

R01AD09

ATC

mometasone; nasal

1.3

8.5

780

5574

Z50.1

ICD-10 Finland

Other physical therapy

1.9

8.5

115

529

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

2.6

8.5

194

Z51.5

ICD-10 Finland

Palliative care

1.7

8.5

194

1054

E66.8

ICD-10 Finland

Other obesity

3.1

8.4

124

C07AB07

ATC

bisoprolol; oral

1.3

8.4

1287

9831

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.6

8.4

247

1433

K92.0

ICD-10 Finland

Haematemesis

2.9

8.3

155

WX212

NOMESCO Finland

Femoral plexus blockade

2.9

8.3

150

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.3

8.3

272

XA420

NOMESCO Finland

Extensive sleep examination

10.0

8.3

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

3.2

8.3

116

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

16.3

8.3

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

0.4

8.3

619

N03AX11

ATC

topiramate; oral

8.8

8.2

R4110

NOMESCO Finland

Physiotherapy

1.3

8.2

622

4319

L29.9

ICD-10 Finland

Pruritus, unspecified

3.0

8.1

135

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

1.6

8.1

208

1168

D01AC02

ATC

miconazole; topical

1.7

8.0

169

897

F51.0

ICD-10 Finland

Nonorganic insomnia

1.7

8.0

162

848

M01AX17

ATC

nimesulide; oral

1.3

8.0

584

4027

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.7

8.0

178

F45.0

ICD-10 Finland

Somatization disorder

78.9

7.9

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

78.9

7.9

F61.0

ICD-10 Finland

Mixed personality disorders

+∞

7.9

RT250

NOMESCO Finland

+∞

7.9

AAD12

NOMESCO Finland

Drainage of subdural fluid

+∞

7.9

IGP01

NOMESCO Finland

Psychiatric family contact

+∞

7.9

34609

ICD-8 Finland

Migraine, Unspecified

+∞

7.9

G24.9

ICD-10 Finland

Dystonia, unspecified

+∞

7.9

AAA20

NOMESCO Finland

Insertion of intraventricular pressure monitoring device

+∞

7.9

183

Kela drug reimbursment

Lamotrigin and topiramate

+∞

7.9

F10.73

ICD-10 Finland

Residual or late-onset psychosis caused by alcohol dementia

+∞

7.9

30300

ICD-8 Finland

Alcoholism, Episodic excessive drinking

+∞

7.9

N04BA03

ATC

levodopa, decarboxylase inhibitor and COMT inhibitor; oral

+∞

7.9

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

+∞

7.9

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

+∞

7.9

PA2VT

NOMESCO Finland

Intravascular evacuation of brain artery embolus

+∞

7.9

F0013, G301

ICD-10 Finland

+∞

7.9

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

+∞

7.9

29530

ICD-8 Finland

Schizophrenia, Paranoid type

+∞

7.9

F23.3

ICD-10 Finland

Other acute predominantly delusional psychotic disorders

+∞

7.9

I61

ICD-10 Finland

Intracerebral haemorrhage

+∞

7.9

AAF25

NOMESCO Finland

Removal of shunt of ventricle of brain

+∞

7.9

G40.6

ICD-10 Finland

Grand mal seizures, unspecified (with or without petit mal)

+∞

7.9

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

+∞

7.9

F32.01

ICD-10 Finland

Mild depressive episode with somatic syndrome

14.3

7.9

L76

ICPC

Fracture: other

2.4

7.9

252

A03FA02

ATC

cisapride; oral, rectal

1.7

7.9

169

903

SPAT1284

SPAT

Extensive health certificate

2.6

7.9

187

E87.6

ICD-10 Finland

Hypokalaemia

2.3

7.9

262

A10AE05

ATC

insulin detemir; parenteral

2.0

7.8

102

462

Z08

ICPC

Social welfare problem

10.1

7.8

R30.0

ICD-10 Finland

Dysuria

2.3

7.8

282

Angiography of the heart and coronary arteries

1.7

7.8

175

948

RS222

NOMESCO Finland

4.7

7.7

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.2

7.6

310

R1260

NOMESCO Finland

Evaluation of communicative skills

3.7

7.6

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

2.8

7.6

153

M54.4

ICD-10 Finland

Lumbago with sciatica

1.5

7.6

261

1570

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

29.2

7.6

G44.0

ICD-10 Finland

Cluster headache syndrome

29.2

7.6

G62.8

ICD-10 Finland

Other specified polyneuropathies

29.2

7.6

SPAT1297

SPAT

Other function in accordance with speech therapy nomenclature

29.2

7.6

F39

ICD-10 Finland

Unspecified mood [affective] disorder

29.2

7.6

A10BB01

ATC

glibenclamide; oral

2.0

7.6

445

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.6

7.5

181

Z46.9

ICD-10 Finland

Fitting and adjustment of unspecified device

3.4

7.5

D07AA02

ATC

hydrocortisone; topical

1.5

7.5

226

1317

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

7.5

946

7018

HA1RA

SPAT

0.1

7.5

260

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.9

7.5

109

514

4471

FHL

Pharyngoplasty

15.0

7.5

I64

ICD-10 Finland

Stroke, not specified as haemorrhage or infarction

19.3

7.5

ACC19

NOMESCO Finland

Transcision of peripheral nerve: other or unspecified

19.3

7.5

KCV12

NOMESCO Finland

Urinary bladder endoscopic botulin therapy

4.5

7.4

A69

ICPC

General and Unspecified, Other reason for encounter NEC

2.6

7.4

187

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

7.3

561

3890

C09AA05

ATC

ramipril; oral

1.3

7.3

675

4808

A10BH05

ATC

linagliptin; oral

1.8

7.3

128

642

H53.4

ICD-10 Finland

Visual field defects

3.5

7.3

R20.2

ICD-10 Finland

Paraesthesia of skin

2.1

7.3

358

R50.9

ICD-10 Finland

Fever, unspecified

1.5

7.3

270

1648

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

0.3

7.3

503

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

4.2

7.3

HMAK

NOMESCO Finland

0.6

7.2

1438

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.7

7.2

143

746

I67.2

ICD-10 Finland

Cerebral atherosclerosis

39.4

7.2

R47.0

ICD-10 Finland

Dysphasia and aphasia

11.4

7.2

N04BC04

ATC

ropinirole; oral

11.4

7.2

R23.8

ICD-10 Finland

Other and unspecified skin changes

0.7

7.2

227

2786

A02BC02

ATC

pantoprazole; systemic

1.2

7.2

1530

12055

SPAT1279

SPAT

Preparation of immediate hospitalisation

4.5

7.1

R54

ICD-10 Finland

Senility

13.2

7.1

H02AA02

ATC

fludrocortisone; oral

5.5

7.1

A04AA55

ATC

palonosetron, combinations; systemic

0.2

7.1

303

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

7.1

166

911

N05CF02

ATC

zolpidem; oral

1.4

7.1

288

1793

R29.6

ICD-10 Finland

Tendency to fall, not elsewhere classified

8.2

7.1

SPAT1094

SPAT

Continuous Positive Airway Pressure

21.9

7.1

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

5.8

7.0

N39.9

ICD-10 Finland

Disorder of urinary system, unspecified

3.3

7.0

F00.24

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms of mixed type

70.1

7.0

I69

ICD-10 Finland

Sequelae of cerebrovascular disease

70.1

7.0

N88

ICPC

Epilepsy

70.1

7.0

F02.09*G31.0

ICD-10 Finland

Dementia in Pick's disease without information on additional symptoms

70.1

7.0

H02BX01

ATC

methylprednisolone, combinations; systemic

1.7

7.0

127

647

JN4AD

NOMESCO Finland

Body CT examination

0.6

7.0

1425

Z01.7

ICD-10 Finland

Laboratory examination

1.5

7.0

248

1501

I50.0

ICD-10 Finland

Congestive heart failure

1.7

7.0

152

817

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.7

6.9

135

700

A86

ICD-10 Finland

Unspecified viral encephalitis

10.4

6.9

AA1XD

NOMESCO Finland

Other special CT of head and brain

10.4

6.9

G63.2

ICD-10 Finland

Diabetic polyneuropathy

10.4

6.9

TPX22

NOMESCO Finland

Intravenous arterial thrombolysis

10.4

6.9

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.7

6.9

130

669

ICC03

NOMESCO Finland

Psychiatric treatment plan, transfer to psychiatric ward

+∞

6.9

S06.8

ICD-10 Finland

Other intracranial injuries

+∞

6.9

I60.2

ICD-10 Finland

Subarachnoid haemorrhage from anterior communicating artery

+∞

6.9

G35

ICD-10 Finland

Multiple sclerosis

+∞

6.9

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

+∞

6.9

G46.4*I67.9

ICD-10 Finland

Cerebellar stroke syndrome

+∞

6.9

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

+∞

6.9

29599

ICD-8 Finland

Schizophrenia, Unspecified type

+∞

6.9

F33.3

ICD-10 Finland

Recurrent depressive disorder, current episode severe with psychotic symptoms

+∞

6.9

AAD05

NOMESCO Finland

Evacuation of acute subdural haematoma

+∞

6.9

I67.4

ICD-10 Finland

Hypertensive encephalopathy

+∞

6.9

ACC53

NOMESCO Finland

Release of ulnar nerve

+∞

6.9

30680

ICD-8 Finland

Special symptoms not elsewhere classified, Cephalalgia

+∞

6.9

F20.5

ICD-10 Finland

Residual schizophrenia

+∞

6.9

P98

ICPC

Psychosis NOS/other

+∞

6.9

29999

ICD-8 Finland

Unspecified psychosis

+∞

6.9

IHZ08

SPAT

+∞

6.9

G46.8*I67.9

ICD-10 Finland

Other vascular syndromes of brain in cerebrovascular diseases

+∞

6.9

4380A

ICD-9 Finland

Late effects of cerebrovascular disease[SEQUELAE MORBI CEREBROVASCULARIS]

+∞

6.9

G40.21

ICD-10 Finland

Partial epileptic seizure with cloudiness and automatism

+∞

6.9

43090

ICD-8 Finland

Subarachnoid haemorrhage, Postaneurysma sacculare, hypertonia non indicata

+∞

6.9

F0021, G301

ICD-10 Finland

+∞

6.9

I60.1

ICD-10 Finland

Subarachnoid haemorrhage from middle cerebral artery

+∞

6.9

L03AA14

ATC

lipegfilgrastim; parenteral

0.2

6.9

281

N05AF01

ATC

flupentixol; systemic

4.0

6.9

U05

ICPC

Urination problems other

1.8

6.9

119

597

SPAT1244

SPAT

Occupational therapy

4.5

6.9

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

0.4

6.8

555

2780A

ICD-9 Finland

Obesity and other hyperalimentation, Obesity

5.9

6.8

XG466

NOMESCO Finland

Sleep oxymetry

3.2

6.8

A03FA01

ATC

metoclopramide; systemic, rectal

0.7

6.8

302

3497

A03CA02

ATC

clidinium and psycholeptics; oral

1.7

6.8

137

723

A10BX01

ATC

guar gum; systemic

1.9

6.7

101

483

103

Kela drug reimbursment

Diabetes, insulin-treated

1.3

6.7

626

4457

XCK10

NOMESCO Finland

Photography of fundus of eye

1.5

6.7

263

1627

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

5.4

6.7

F33.8

ICD-10 Finland

Other recurrent depressive disorders

26.3

6.7

Z75.0

ICD-10 Finland

Medical services not available in home

26.3

6.7

ZXA05

NOMESCO Finland

Left side

1.3

6.7

647

4632

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

6.6

459

3134

A02BA04

ATC

nizatidine; systemic

1.6

6.6

166

928

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

2.2

6.6

240

WF049

NOMESCO Finland

Radiotherapy of metastasis

0.4

6.6

575

D10

ICPC

Vomiting

2.5

6.5

164

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

6.0

6.5

S00.8

ICD-10 Finland

Superficial injury of other parts of head

3.4

6.5

U29

ICPC

Urinary symptom/complaint other

2.1

6.5

295

NFJ54

NOMESCO Finland

Internal fixation of fracture of upper femur with intramedullary nail

3.1

6.5

SPAT1157

SPAT

Guidance concerning treatment of mouth and mucous membranes

3.1

6.5

N40

ICD-10 Finland

Hyperplasia of prostate

1.3

6.4

644

4628

F41.09

ICD-10 Finland

UNS Panic Syndrome

5.4

6.4

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

5.4

6.4

S72.4

ICD-10 Finland

Fracture of lower end of femur

5.4

6.4

E16.0

ICD-10 Finland

Drug-induced hypoglycaemia without coma

8.8

6.4

S22.4

ICD-10 Finland

Multiple fractures of ribs

2.7

6.4

139

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.4

6.4

177

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.4

6.4

194

G31.9

ICD-10 Finland

Degenerative disease of nervous system, unspecified

35.0

6.3

F41.3

ICD-10 Finland

Other mixed anxiety disorders

35.0

6.3

Z72.1

ICD-10 Finland

Alcohol use

5.7

6.3

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.7

6.3

125

115

Kela drug reimbursment

Breast cancer

0.6

6.3

1388

L84

ICD-10 Finland

Corns and callosities

2.1

6.3

306

SPAT1042

SPAT

Guidance concerning balance maintenance

5.3

6.3

I50

ICD-10 Finland

Heart failure

2.0

6.2

308

WX892

NOMESCO Finland

Monitored bed care

1.6

6.2

156

871

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.1

6.2

266

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

2.4

6.2

191

PA2CC

NOMESCO Finland

Cerebral very extensive angiography with X-ray

19.7

6.2

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

1.9

6.2

434

A10AD01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

3.2

6.2

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.7

6.2

122

SPAT1153

SPAT

Removal of sutures

0.8

6.2

643

6677

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.3

6.2

575

4090

XCH00

NOMESCO Finland

Eye pressure measurement

0.5

6.2

662

P27

ICPC

Fear of mental disorder

8.1

6.2

S52.5

ICD-10 Finland

Fracture of lower end of radius

1.5

6.1

235

1447

7865A

ICD-9 Finland

Symptoms involving respiratory system and other chest symptoms, Chest pain

2.5

6.1

154

J01MA06

ATC

norfloxacin; oral

1.4

6.1

278

1768

P74

ICPC

Anxiety disorder/anxiety state

3.7

6.1

SPAT1127

SPAT

Enema

4.3

6.1

F31

ICD-10 Finland

Bipolar affective disorder

61.4

6.1

Z98.2

ICD-10 Finland

Presence of cerebrospinal fluid drainage device

61.4

6.1

E44.1

ICD-10 Finland

Mild protein-energy malnutrition

61.4

6.1

IGV01

NOMESCO Finland

Psychiatric network contact

61.4

6.1

G44.1

ICD-10 Finland

Vascular headache, not elsewhere classified

61.4

6.1

AAF99

NOMESCO Finland

Other shunt operation on ventricle of brain or intracerebral cyst

61.4

6.1

G93.0

ICD-10 Finland

Cerebral cysts

61.4

6.1

S02.11

ICD-10 Finland

Fracture of base of skull, open

61.4

6.1

F22.8

ICD-10 Finland

Other persistent delusional disorders

61.4

6.1

PJA12

NOMESCO Finland

Sentinel node biopsy

0.6

6.1

1300

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

0.5

6.0

859

R44.1

ICD-10 Finland

Visual hallucinations

10.7

6.0

UJF32

NOMESCO Finland

Coloscopy

1.3

6.0

618

4451

R07.2

ICD-10 Finland

Precordial pain

2.4

6.0

182

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

1.8

6.0

478

R15

ICD-10 Finland

Faecal incontinence

2.1

6.0

247

N30

ICD-10 Finland

Cystitis

1.6

6.0

133

721

L03AA02

ATC

filgrastim; parenteral

0.4

6.0

461

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

374

175

15.01

322.83

1.2

1.1

477.6

593.2

mg/l

2.11

329

168

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

371

62.18

307.65

1.0

541.4

824.7

ng/l

4.02

259

(3019309) Folate [Moles/volume] in Red Blood Cells

2805

7000

3.81

307.65

1.9

1.7

1214.0

1125.9

nmol/l

4.23

1967

4990

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

371

62.18

307.65

1.0

56.8

42.2

ng/l

1.82

266

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

368

60.21

307.65

1.0

427.7

343.6

ng/l

1.78

266

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

333

138

16.85

303.04

1.3

1.2

195.9

214.7

e6/l

0.06

262

110

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

333

138

16.85

303.04

1.2

1.1

6.9

66.8

e6/l

0.83

257

100

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

327

152

15.01

282.84

1.2

1.1

3.8

3.7

mmol/l

0.61

302

143

(3044290) Cell count panel - Cerebral spinal fluid

301

150

13.94

251.72

1.2

1.1

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2091

6998

2.42

209.89

3.1

3.4

2.5

mmol/l

8.33

1822

6048

(3015377) Calcium [Moles/volume] in Serum or Plasma

2922

11832

2.12

180.42

2.6

3.6

2.4

mmol/l

1.05

2452

9922

(3023410) Appearance of Cerebral spinal fluid

172

20.98

171.04

1.3

1.1

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3463

15378

2.01

160.88

2.5

2.0

90.2

91.9

pmol/l

1.14

1742

7520

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2166

8105

2.14

159.27

2.2

1.7

261.0

217.7

u/l

1.10

1982

7292

(3021960) Folate [Moles/volume] in Serum or Plasma

2234

8878

2.00

135.59

1.7

1.5

20.8

20.2

nmol/l

0.77

1969

7326

(3024561) Albumin [Mass/volume] in Serum or Plasma

3332

15504

1.84

122.19

3.7

4.5

34.4

34.1

g/l

1.54

2956

14114

(3031040) Bacteria [#/volume] in Urine by Automated count

4431

22535

1.87

122.15

6.1

4.5

3432.4

1468.3

e6/l

1.04

132

339

(3023368) Bacteria identified in Blood by Culture

2412

10184

1.89

119.29

4.1

—

(3026008) Bacteria identified in Urine by Culture

2662

11707

1.84

114.83

3.8

3.1

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1552

5701

2.05

113.60

1.9

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1172

3940

2.18

107.06

1.9

1.6

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

681

1811

2.67

103.32

1.6

1.4

—

(3016018) Differential panel - Cerebral spinal fluid

138

10.90

102.08

1.2

1.1

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1161

3978

2.14

100.59

1.9

1.6

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2810

13035

1.74

96.57

4.7

3.6

57.3

83.6

ng/l

0.99

2220

10104

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1819

7485

1.84

92.79

1.8

1.7

447.6

26906895.4

pmol/l

4.77

1418

5783

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3295

16415

1.65

82.44

4.4

5.3

1.2

mmol/l

0.87

2866

14475

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2471

11424

1.69

82.32

2.5

1.8

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2634

12665

1.62

73.01

2.1

78.0

82.2

nmol/l

8.33

2212

10751

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

690

8456

0.49

65.19

1.4

1.6

1.2

mmol/l

2.91

585

6762

(3022217) INR in Platelet poor plasma by Coagulation assay

1331

5475

1.77

64.63

29.4

30.7

1.7

1.6

inr

1.10

779

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3489

18268

1.55

64.59

4.8

6.1

1.2

mmol/l

8.11

2823

15152

(3018418) pH of Serum or Plasma

2279

10887

1.59

62.30

3.0

4.0

7.4

1.42

332

2010

(3013826) Glucose [Moles/volume] in Serum or Plasma

3671

19537

1.54

62.14

4.3

4.1

7.0

6.9

mmol/l

3.46

3448

18185

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2026

9432

1.61

61.46

2.3

2.2

3.0

3.1

mg/l

1.21

1629

7931

(3019150) Specific gravity of Urine by Refractometry

1514

6626

1.67

58.05

5.3

4.1

1.0

kg/l

1.62

238

1085

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

351

939

2.57

51.81

1.2

—

(40768804) Tissue Pathology biopsy report

1495

14064

0.63

50.92

2.2

2.4

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

818

3141

1.84

48.67

2.5

2.2

5.5

7.1

ug/l

1.95

596

2703

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

636

2249

1.98

48.43

1.9

1.6

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1294

12363

0.63

46.00

3.2

3.9

12.4

8.3

mg/mmol

1.51

772

7561

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

378

1119

2.32

44.97

1.4

1.3

1.6

1.7

0.07

304

864

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1028

4349

1.68

43.42

1.7

1.9

29.8

30.5

2.76

987

4223

(3015736) pH of Urine

2386

12239

1.46

42.57

4.3

3.5

—

5.8

—

(40761535) Cells panel - Urine sediment

736

2870

1.79

41.30

3.9

3.3

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1594

7581

1.52

40.98

4.5

3.5

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3957

30202

0.70

40.32

3.9

4.6

1.5

mmol/l

3.22

3335

26106

(3037467) Urinalysis macro (dipstick) panel - Urine

4036

22925

1.42

40.20

5.1

4.3

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

6.56

40.04

1.4

1.1

—

(3012516) Albumin [Mass/volume] in Urine

1229

11595

0.64

39.90

2.6

3.1

480.3

300.7

mg/l

0.66

744

7097

(3009508) Creatinine [Moles/volume] in Urine

1231

11589

0.64

39.46

2.5

3.1

7.2

6.7

mmol/l

3.59

942

9371

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

118

5.20

38.00

2.3

2.2

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4044

30599

0.71

37.07

3.9

4.6

4.3

4.5

mmol/l

11.77

3413

26716

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

614

2381

1.79

34.85

1.5

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

295

882

2.28

34.26

1.9

2.2

1541.0

634.1

ug/l

0.65

276

842

(3035350) Ketones [Presence] in Urine by Test strip

2858

15648

1.37

32.51

4.6

3.7

0.0

estimate

0.00

402

3026

(3029937) Albumin [Presence] in Urine by Test strip

1703

8565

1.43

31.70

5.2

4.0

0.0

estimate

0.00

368

2838

(1761868) Lipid panel - Serum or Plasma

781

7804

0.62

31.62

3.0

3.6

—

(4035726)

284

3752

0.48

31.22

1.2

1.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

167

396

2.86

30.94

1.1

1.2

—

(3018095) Leukocytes [#/volume] in Urine

2391

12791

1.38

30.94

4.2

3.6

146.8

144.6

e6/l

0.02

1712

9129

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

263

795

2.25

29.79

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

263

795

2.25

29.79

1.4

1.3

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3852

28958

0.74

29.08

3.5

4.1

1.2

mmol/l

0.43

3198

24691

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

5172

31363

1.40

29.05

20.2

15.2

32.7

29.5

mg/l

6.78

4446

24968

(36304419) Bacteria [Presence] in Urine

1879

9766

1.39

28.42

3.5

3.1

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3858

22430

1.33

27.74

3.7

3.8

15.2

15.3

pmol/l

0.58

3288

19350

(3014271) Vancomycin [Susceptibility]

159

3.90

27.61

3.5

2.6

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1424

7102

1.42

27.11

4.2

3.6

236.9

621.0

ng/l

5.09

1284

6302

(3021601) Nitrite [Presence] in Urine by Test strip

2830

15763

1.33

27.10

6.0

5.1

0.0

estimate

0.00

391

3009

(3009261) Glucose [Presence] in Urine by Test strip

2860

15963

1.33

26.96

4.7

3.8

0.0

estimate

0.50

398

2985

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4310

31715

0.75

26.15

4.6

5.3

2.5

2.6

mmol/l

13.37

3708

27594

(3002582) Erythrocytes [#/volume] in Urine

2107

11298

1.35

25.66

3.7

3.2

81.8

122.6

e6/l

1.09

1630

8607

(3003338) MCHC [Mass/volume]

4108

24274

1.32

25.05

27.0

21.9

329.8

330.4

g/l

4.54

3996

24041

(3003694) ABO and Rh group [Type] in Blood

891

8258

0.68

24.15

1.2

1.3

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

5.88

23.76

1.0

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

223

2914

0.49

23.47

1.3

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

4133

30430

0.76

23.45

19.6

15.8

67.9

68.1

ml/min/173m2

0.27

3260

24635

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2157

11745

1.33

23.12

5.3

4.1

—

(3023183) Ammonium ion [Moles/volume] in Plasma

159

434

2.48

22.61

1.6

1.8

24.6

34.2

umol/l

8.37

124

342

(3000850) Epithelial cells [#/volume] in Urine

1490

7726

1.36

21.88

2.8

2.6

5.2

5.1

e6/l

0.10

1299

6652

(3006653) Thiamine [Moles/volume] in Blood

7.06

21.71

1.1

135.7

132.1

nmol/l

0.11

(3043409) Potassium [Moles/volume] in Arterial blood

286

1011

1.92

21.57

2.8

3.7

3.9

mmol/l

0.21

254

942

(3006270) Folate [Moles/volume] in Blood

108

249

2.92

21.14

1.3

1.2

291.4

299.0

nmol/l

0.13

179

(3024891) Influenza virus A+B Ag [Presence] in Specimen

192

589

2.21

21.08

1.2

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4661

28339

1.30

20.63

4.9

4.6

2.0

2.2

mu/l

10.20

4073

24410

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1191

6007

1.39

20.58

3.2

2.9

2.8

3.0

e6/l

0.23

674

3363

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

220

727

2.05

20.04

1.2

1.1

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1251

6396

1.37

19.82

2.9

2.8

1.6

1.7

e6/l

0.16

727

3740

(3014765) Yersinia sp identified in Stool by Organism specific culture

221

735

2.04

19.79

1.2

1.1

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

511

2190

1.60

19.77

4.5

5.9

24.4

24.3

mmol/l

0.53

495

2016

(42529406) Shigella sp [Presence] in Stool by Culture

221

738

2.03

19.58

1.2

1.1

—

(3030467) Casts [#/volume] in Urine by Automated count

1913

10434

1.31

19.53

3.5

3.1

0.6

0.5

e6/l

0.27

1484

7790

(3002256) Pathology report gross observation

518

5149

0.64

19.48

1.4

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

6.08

19.14

1.1

1.0

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

6.34

18.37

1.1

1.0

0.7

0.6

promille

0.10

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2653

15185

1.27

18.25

2.8

49.9

59.7

u/l

5.67

2268

13137

(3019060) Gas panel - Arterial blood

524

2320

1.55

17.61

3.2

3.9

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

4.53

17.54

1.2

1.1

2.1

mmol/l

0.02

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2174

12189

1.28

17.53

2.6

2.7

145.1

169.3

ug/l

3.74

1859

10884

(3004716) Salmonella sp identified in Stool by Organism specific culture

233

829

1.90

17.29

1.2

—

(3002179) Metamyelocytes/100 leukocytes in Blood

229

2693

0.55

16.98

2.9

3.8

0.7

0.13

669

(3003396) Base excess in Arterial blood by calculation

844

4146

1.41

16.76

3.6

5.8

1.1

0.9

mmol/l

0.94

644

3188

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

905

4515

1.39

16.39

9.9

7.2

—

(3024354) Oxygen [Partial pressure] in Venous blood

611

2840

1.48

16.30

2.4

2.8

4.1

4.3

kpa

1.86

577

2754

(3021440) Promyelocytes/100 leukocytes in Blood

255

2847

0.58

15.59

2.9

3.8

0.2

0.1

0.88

874

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

113

1623

0.46

15.56

2.8

4.6

159.4

78.3

u/ml

0.93

105

1564

(3017181) Myelocytes/100 leukocytes in Blood

272

2983

0.59

15.50

2.8

3.8

1.0

0.8

0.34

924

(3026782) Osmolality of Urine

1384

7433

1.30

15.22

3.0

2.7

565.6

552.4

mosm/kgh2o

1.58

1138

6202

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

830

4161

1.37

14.50

3.6

5.8

4.9

5.0

kpa

4.32

786

3921

(3027801) Oxygen [Partial pressure] in Arterial blood

829

4159

1.37

14.42

3.6

5.8

11.3

12.0

kpa

3.56

786

3920

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1773

9886

1.26

14.36

2.2

2.4

59.3

63.0

u/l

1.22

1578

8968

(3014111) Lactate [Moles/volume] in Serum or Plasma

651

3136

1.42

14.35

3.3

5.5

1.5

1.3

mmol/l

6.25

624

3008

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

395

3901

0.66

14.17

1.2

9.6

21.1

u/ml

2.83

1236

(3025159) Blasts/100 leukocytes in Blood

239

2622

0.59

13.62

2.9

3.8

0.0

0.5

1.93

715

(3020891) Body temperature

319

1337

1.62

13.53

3.3

4.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

4.55

13.28

1.1

1.0

—

(4027681)

7.32

13.22

1.1

1.4

—

(3003181) Sodium [Moles/volume] in Urine

163

567

1.94

13.02

1.3

65.5

60.8

mmol/l

0.78

127

457

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

559

5096

0.71

12.99

2.7

4.3

26.1

26.0

ug/l

0.00

450

4312

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

4.66

12.14

1.1

51.2

43.9

mg/l

0.30

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

362

1612

1.52

11.86

2.5

3.7

24.1

mmol/l

0.06

321

1455

(3033658) Prothrombin time (PT) actual/Normal

1476

8210

1.25

11.85

3.4

3.7

79.9

82.3

2.98

1425

8041

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

9.47

11.64

1.1

1.2

26.4

65.0

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

4.21

11.52

1.1

1.0

—

(4034850)

225

904

1.68

11.29

11.2

11.0

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

4226

26173

1.20

10.99

5.6

7.6

81.5

83.4

u/l

1.29

3819

24264

(3016502) Oxygen saturation in Arterial blood

727

3725

1.34

10.93

3.7

6.0

94.5

95.3

1.67

705

3556

(3007853) Bacteria identified in Skin by Aerobe culture

692

3531

1.34

10.69

1.7

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

246

2529

0.64

10.63

1.6

1.5

—

(3021589) Normoblasts [#/volume] in Blood

1935

14742

0.83

10.55

9.3

9.9

0.0

e9/l

0.75

1525

11880

(3021447) Carbon dioxide [Partial pressure] in Venous blood

679

3467

1.34

10.44

2.6

3.4

5.8

kpa

1.30

645

3372

(3032080) INR in Blood by Coagulation assay

2570

15277

1.19

10.39

10.7

1.3

1.4

inr

1.66

609

4106

(40761511) CBC panel - Blood by Automated count

5080

32077

1.21

10.32

18.9

15.2

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

446

2130

1.42

10.30

1.7

2.3

406.8

396.8

nmol/l

0.44

369

1951

(3002032) Base excess in Venous blood by calculation

679

3474

1.34

10.29

2.6

3.4

2.0

1.8

mmol/l

0.49

550

2740

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

458

4136

0.72

9.95

1.2

35.8

50.5

iu/ml

1.29

138

1258

(3052592) Norovirus Ag [Presence] in Stool

3.89

9.87

1.3

—

(3027945) Reticulocytes/100 erythrocytes in Blood

918

4922

1.28

9.86

2.0

2.3

1.8

1.7

0.22

717

4329

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

684

0.35

9.80

1.5

1.8

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

437

0.20

9.67

1.4

1.5

—

(3022145) Colonoscopy Study observation

392

3587

0.71

9.22

1.3

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

579

2941

1.34

9.21

2.1

2.3

33.7

39.4

u/l

1.40

469

2529

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

731

3853

1.30

8.94

4.5

3.2

—

(3040151) Glucose [Moles/volume] in Capillary blood

110

384

1.92

8.84

7.5

5.5

7.3

7.2

mmol/l

0.11

315

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4484

31571

0.85

8.79

4.6

5.1

6.2

6.1

mmol/l

2.78

3801

27302

(1002224) Polysomnography panel

176

2.40

8.79

1.0

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

998

0.49

8.66

1.9

3.2

144.2

829.2

u/ml

2.57

913

(3013707) Erythrocyte sedimentation rate by Westergren method

3779

23415

1.17

8.65

3.7

4.1

16.5

16.1

mm/h

0.60

3284

20806

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

3.58

8.58

1.3

1.5

73.6

67.3

umol/l

0.12

(3016038) Potassium [Moles/volume] in Urine

220

2.19

8.24

1.1

36.1

38.4

mmol/l

0.32

182

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

717

3826

1.28

7.95

3.2

2.7

242.5

274.6

ng/l

1.04

657

3539

(3008295) Osmolality of Serum or Plasma

277

2.03

7.95

1.4

1.2

275.4

275.1

mosm/kgh2o

0.03

209

(3002173) Hemoglobin [Mass/volume] in Arterial blood

648

3418

1.29

7.87

3.8

6.3

121.1

117.8

g/l

3.77

633

3278

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

362

1754

1.40

7.75

2.8

3.5

2.2

2.0

mmol/l

0.46

253

1249

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

4.01

7.74

1.0

1.1

—

(3037522) Nuclear Ab [Titer] in Serum

343

3117

0.72

7.74

1.2

1.3

473.9

510.4

titre

0.17

735

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

542

0.35

7.72

1.1

1.2

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

520

4436

0.76

7.61

4.3

4.8

34.4

33.8

0.52

275

2489

(40757373) Influenza virus identified in Isolate

3.47

7.46

1.3

1.2

—

(40768793) Breast Pathology biopsy report

750

0.46

7.43

1.2

1.3

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2127

15712

0.86

7.27

3.8

4.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

198

1962

0.66

7.25

1.3

—

(40768800) Prostate Pathology biopsy report

1110

0.56

7.21

1.2

—

(3009542) Hematocrit [Volume Fraction] of Blood

4265

26849

1.15

7.20

22.9

17.9

36.8

37.3

2.16

2361

15530

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2916

17874

1.15

7.15

3.9

6.4

12.9

12.8

umol/l

0.16

2626

16931

(4010399)

226

2175

0.68

7.11

1.4

—

(3028026) IgM [Mass/volume] in Serum or Plasma

161

1657

0.64

7.08

1.8

2.0

1.8

1.5

g/l

0.34

127

1480

(3009343) pH of Capillary blood

368

1821

1.37

6.97

2.9

3.6

7.4

0.93

264

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

882

0.52

6.93

1.2

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

372

1851

1.36

6.81

2.9

3.6

5.2

5.1

kpa

1.73

323

1677

(3025941) Bacteria identified in Stool by Culture

279

1327

1.42

6.69

1.3

—

(40768795) Lymph node Pathology biopsy report

416

0.32

6.68

1.2

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1135

8750

0.84

6.45

2.3

2.9

9454.6

8129.9

umol/l

0.30

888

7255

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

276

1322

1.41

6.38

1.9

1.7

—

(3013512) EKG study

1512

11360

0.86

6.25

4.4

4.2

—

(4281824)

449

0.37

6.19

1.2

1.1

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

323

1604

1.36

6.03

1.8

3.5

2.3

ug/l

0.38

244

1414

(3024869) Neuronal Ab [Presence] in Serum

6.68

5.87

1.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4293

29997

0.88

5.86

6.3

6.4

41.9

40.6

mmol/mol

10.90

3707

26394

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

293

0.25

5.82

1.3

1.4

—

(3005719) IgG [Mass/volume] in Serum or Plasma

219

2037

0.71

5.75

2.7

2.9

10.7

10.8

g/l

0.13

183

1866

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

3.27

5.69

2.6

1.9

0.4

0.6

u/field

0.32

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

301

2658

0.74

5.68

3.0

2.8

52.9

56.8

ml/min/173m2

1.94

113

1203

(4094501)

767

0.54

5.48

1.0

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

207

1.97

5.47

1.3

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

5301

34140

1.15

5.43

24.1

18.5

139.7

139.5

mmol/l

3.46

5089

32985

(3010421) pH of Blood

193

894

1.45

5.41

3.6

3.9

7.4

0.46

152

748

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2118

12892

1.14

5.32

3.0

2332.8

1911.7

ng/l

2.85

1770

11303

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

289

1443

1.35

5.25

1.9

1.8

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

5303

34181

1.15

5.22

24.2

18.8

4.0

mmol/l

1.30

5080

32969

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

4.45

5.14

1.1

1.0

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

203

1.95

5.12

1.3

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

919

5270

1.19

5.11

2.1

2.8

0.8

mmol/l

0.44

783

4828

(3014891) Appearance of Pleural fluid

2.62

4.99

1.4

1.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.39

4.90

1.7

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.39

4.90

1.7

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

185

1719

0.71

4.88

2.2

3.3

174.6

3175.0

u/ml

2.77

141

1472

(40758558) Short blood count panel - Blood

1394

8296

1.15

4.82

5.1

6.9

—

(21494755) Public health laboratory ask at order entry panel

172

0.23

4.77

1.2

1.4

—

(3032057) Clostridioides difficile [Presence] in Stool

2.65

4.77

1.5

—

(3010813) Leukocytes [#/volume] in Blood

5335

34487

1.14

4.58

28.2

23.5

7.2

6.9

e9/l

7.55

5059

32819

(3045142) Bone marrow Pathology biopsy report

491

0.49

4.56

1.2

1.3

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

209

1016

1.38

4.54

3.2

4.2

25.2

24.6

mmol/l

1.55

170

901

(40768443) Skin Pathology biopsy report

177

1635

0.71

4.53

1.2

—

(3007461) Platelets [#/volume] in Blood

5332

34478

1.14

4.49

28.1

23.5

235.0

237.9

e9/l

2.31

5072

32974

(3035941) MCH [Entitic mass]

5332

34482

1.14

4.47

28.0

23.4

30.4

0.13

5130

33596

(3024731) MCV [Entitic volume]

5332

34483

1.14

4.46

28.1

23.4

92.0

91.9

0.69

5131

33598

(3026361) Erythrocytes [#/volume] in Blood

5332

34483

1.14

4.46

28.2

23.5

4.2

4.3

e12/l

51.63

5051

32805

(3000963) Hemoglobin [Mass/volume] in Blood

5332

34485

1.14

4.44

28.4

23.6

127.6

131.4

g/l

61.32

5126

33606

(3000492) Spirometry study

230

2025

0.75

4.32

1.5

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

463

0.49

4.30

2.0

2.2

125.3

279.7

u/ml

0.42

455

(40760892) CBC W Ordered Manual Differential panel - Blood

778

5995

0.85

4.29

3.5

4.6

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.25

4.21

1.1

1.3

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

795

0.62

4.10

1.3

1.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

306

0.39

4.07

1.2

—

(3004809) Band form neutrophils/100 leukocytes in Blood

711

0.60

4.07

3.3

3.5

3.0

1.4

1.06

529

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

317

1667

1.28

4.06

2.2

2.3

0.7

1.83

303

1601

(3044242) Glucose [Moles/volume] in Arterial blood

178

1.88

4.01

1.4

2.1

—

(3028717) Thiamine [Mass/volume] in Blood

8.90

3.92

1.1

1.5

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

3.46

3.81

1.1

1.0

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

3.46

3.81

1.1

1.0

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

6.67

3.76

1.0

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

734

0.62

3.70

1.7

1.5

15.5

12.1

mg/l

2.00

659

(3017354) Segmented neutrophils/100 leukocytes in Blood

438

0.52

3.69

3.2

3.6

57.3

58.5

0.07

254

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

494

2761

1.21

3.68

2.7

3.5

85.6

96.1

ng/l

1.96

393

2269

(3014576) Chloride [Moles/volume] in Serum or Plasma

815

4757

1.16

3.65

3.9

5.8

104.6

104.4

mmol/l

0.32

780

4656

(3051651) Icteric interference index of Serum or Plasma

190

1.80

3.59

3.5

4.1

—

(3051593) INR in Capillary blood by Coagulation assay

134

1.95

3.50

7.7

26.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

273

2282

0.79

3.49

1.2

—

(3012501) Base excess in Blood by calculation

158

770

1.38

3.47

3.9

4.1

2.8

2.7

mmol/l

0.11

109

504

(3013290) Carbon dioxide [Partial pressure] in Blood

158

771

1.37

3.45

3.9

4.1

5.0

4.9

kpa

0.24

152

749

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

530

0.58

3.43

1.2

1.1

—

(3036489) Thrombin time

158

772

1.37

3.43

1.8

1.9

20.7

22.6

3.12

145

685

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.45

3.41

1.4

1.2

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

579

0.60

3.40

1.2

6.3

u/ml

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

144

1304

0.73

3.35

1.1

70.6

135.5

iu/ml

1.38

423

(40768441) Liver Pathology biopsy report

232

0.37

3.35

1.0

1.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

576

0.60

3.34

1.2

1.4

3.8

u/ml

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

140

0.29

3.31

1.0

1.1

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

620

3573

1.17

3.28

2.1

2.6

10.6

11.8

umol/l

0.47

494

3137

(3005322) IgE [Units/volume] in Serum or Plasma

127

1168

0.72

3.27

1.2

335.6

249.1

u/ml

0.54

110

1048

(3047181) Lactate [Moles/volume] in Blood

203

1039

1.31

3.26

3.8

4.9

1.4

mmol/l

0.48

188

918

(40768797) Stomach Pathology biopsy report

559

4322

0.85

3.23

1.2

1.3

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

660

5037

0.86

3.23

2.7

4.2

250.1

253.9

u/l

0.23

576

4748

(3024928) Oxygen saturation in Venous blood

145

707

1.38

3.21

1.7

2.6

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

126

0.26

3.21

1.0

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.21

3.20

1.2

1.0

—

(3027315) Oxygen [Partial pressure] in Blood

157

776

1.36

3.19

4.0

4.1

7.9

8.3

kpa

2.91

150

754

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

364

0.51

3.18

1.1

154.1

1043.9

iu/ml

—

(3028707) Methadone [Presence] in Urine by Screen method

5.93

3.17

1.0

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.54

3.17

1.3

1.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.02

3.14

1.9

2.0

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

2.86

3.10

1.3

1.1

1.3

u/l

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

3.10

3.04

1.2

1.0

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

143

0.33

3.02

1.9

2.3

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

162

815

1.33

2.96

2.2

2.1

126.1

123.9

g/l

0.49

128

587

(3022313) Gas panel - Capillary blood

235

1247

1.27

2.90

3.0

3.9

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

521

0.61

2.89

1.2

1.1

9.9

u/ml

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.39

2.85

1.0

1.1

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

170

867

1.32

2.85

2.5

3.1

25.0

24.8

mmol/l

0.34

155

756

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

5.84

2.80

1.0

—

(3018572) Chloride [Moles/volume] in Blood

151

759

1.33

2.80

4.0

5.4

104.1

104.8

mmol/l

0.95

144

671

(3039000) Anion gap in Blood

151

759

1.33

2.80

4.0

5.4

11.3

11.4

mmol/l

0.07

144

671

(1616796) Gas panel - Central venous blood

151

761

1.33

2.76

3.3

3.6

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.89

2.75

1.2

1.0

—

(21494434) Karyotype in Bone marrow

439

0.59

2.74

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

302

1.53

2.73

1.4

—

(3000330) Specific gravity of Urine by Test strip

280

2264

0.82

2.71

4.3

3.7

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

407

1.45

2.68

1.9

1.5

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1090

7957

0.90

2.66

3.0

3.6

0.9

ug/l

0.66

788

6062

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

536

3110

1.16

2.65

1.6

2.0

0.2

g/l

0.05

446

2882

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1017

6158

1.12

2.63

1.6

1.8

mg/l

0.08

784

4851

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.80

2.61

2.0

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

2.42

2.61

1.1

1.3

82.8

139.0

ug/l

0.91

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

5.19

2.60

1.3

1.0

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

808

0.71

2.59

2.1

3.8

3.7

g/l

0.09

766

(3004588) Protein electrophoresis panel - Serum or Plasma

477

2749

1.17

2.58

2.2

2.6

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

114

1022

0.74

2.57

1.5

1.4

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

241

0.47

2.56

2.6

3.8

—

(3042631) Mycobacterium sp identified in Specimen

615

0.67

2.52

2.3

2.9

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

3.75

2.51

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

3.75

2.51

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

3.75

2.51

1.0

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

590

0.66

2.50

2.5

3.7

38.8

54.5

u/ml

0.57

573

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

0.00

2.49

0.0

1.0

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

262

1435

1.23

2.49

2.1

2.4

0.4

0.3

u/ml

1.27

154

749

(3024980) IgG subclass 4 [Mass/volume] in Serum

377

0.58

2.48

1.6

1.5

0.7

0.9

g/l

0.32

265

(40767503) Oxygen content in Capillary blood by calculation

147

751

1.31

2.48

2.5

2.3

16.3

15.4

1.51

381

(1001926) Buprenorphine [Presence] in Urine by Screen method

4.11

2.46

1.0

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

213

1751

0.81

2.45

1.8

1.9

9.8

10.0

nmol/l

0.15

173

1466

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

340

0.57

2.41

1.0

1.1

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

215

1157

1.25

2.41

1.2

1.3

50.6

59.0

au/ml

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

559

0.67

2.37

1.1

—

(44806420)

187

0.43

2.34

1.9

2.4

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

129

0.36

2.34

1.0

1.5

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

129

0.36

2.34

1.0

1.5

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

196

1.60

2.33

2.5

1.9

1.8

2.8

u/field

0.50

123

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

0.00

2.32

0.0

1.0

—

(3024471) HLA-A [Type]

0.00

2.32

0.0

1.0

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

186

0.43

2.31

5.5

6.4

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

122

1064

0.76

2.30

1.5

1.6

39.0

38.6

u/l

0.06

881

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

3.03

2.29

1.0

—

(3022621) pH of Urine by Test strip

408

2349

1.17

2.27

4.2

3.3

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

678

0.70

2.24

1.5

1.6

—

(3000991) Gas panel - Venous blood

516

3029

1.15

2.22

3.6

6.6

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

3.56

2.18

1.3

1.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

311

0.58

2.14

1.5

1.7

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

418

0.64

2.13

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

268

0.55

2.13

1.0

1.2

18.3

14.3

u/l

0.50

213

(3021901) Oxygen saturation in Capillary blood

132

681

1.30

2.12

2.5

2.8

—

(3024932) HLA-DR beta [Type]

0.00

2.12

0.0

1.1

—

(3011288) Drugs identified in Urine by Screen method

3.89

2.11

1.3

1.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

425

0.64

2.11

4.2

3.9

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

125

1070

0.77

2.08

1.6

90.0

249.5

titre

—

(3008898) HLA-B27 [Presence]

374

0.62

2.07

1.0

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

2.05

2.06

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

230

1273

1.21

2.03

1.9

2.1

36.2

36.6

g/l

0.36

162

1059

(3015171) Extractable nuclear Ab [Units/volume] in Serum

848

0.75

2.03

1.3

1.2

0.6

0.9

u/ml

0.24

(3052851) Hemolysis interference index of Serum or Plasma

196

1068

1.23

2.02

3.5

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

175

0.46

2.01

1.1

1.4

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

175

0.46

2.01

1.1

1.4

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

175

0.46

2.01

1.1

1.4

—

(1617658) Protocol used for examination of sentinel lymph nodes

296

0.58

2.00

1.1

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

177

1446

0.81

1.98

2.5

2.7

—

(3020630) Protein [Mass/volume] in Serum or Plasma

577

3441

1.13

1.98

2.1

2.7

65.4

65.8

g/l

0.68

461

3081

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

319

0.60

1.95

1.0

1.1

283.8

263.6

u/ml

0.13

185

(3042733) HLA Ab [Presence] in Serum

0.00

1.95

0.0

4.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

161

863

1.25

1.94

4.4

3.2

33.0

29.6

mg/l

0.47

119

570

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

361

1.39

1.93

2.5

2.3

2.2

1.9

u/field

0.28

114

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

189

0.49

1.91

1.0

1.1

46.7

27.9

u/l

—

133

(3051611) Lipemic interference index of Serum or Plasma

413

1.36

1.91

3.3

3.5

—

(3022948) Iron [Moles/volume] in Serum or Plasma

976

6003

1.10

1.89

2.1

2.4

10.8

11.8

umol/l

5.45

844

5547

(3027456) Digoxin [Moles/volume] in Serum or Plasma

209

1157

1.21

1.87

3.7

3.1

0.8

nmol/l

0.05

155

895

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

403

0.66

1.84

1.2

—

20.7

—

(21494814) CD8 cells/100 lymphocytes in Specimen

116

0.40

1.83

5.0

1.6

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

354

1.38

1.82

1.9

1.5

33.6

24.6

u/ml

0.82

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

131

0.46

1.78

1.1

1.5

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

664

0.74

1.78

3.1

2.1

209.6

218.8

0.39

622

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

716

0.75

1.76

2.0

1.9

90.1

86.0

0.93

671

(3030981) Hyaline casts [#/volume] in Urine by Automated count

355

2068

1.15

1.76

3.4

2.7

0.4

0.3

e6/l

0.34

350

2035

(3006462) Nitrate [Presence] in Urine

183

0.51

1.75

3.2

3.9

—

(3025130) Human papilloma virus identified in Specimen

174

0.50

1.75

2.5

1.6

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

342

1991

1.15

1.72

3.7

6.0

24.7

24.6

mmol/l

0.14

337

1969

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

258

0.59

1.71

1.2

1.1

6.5

8.4

mmol/l

2.49

153

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

543

0.72

1.69

1.2

1.4

0.8

0.7

nmol/l

0.20

447

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

0.37

1.67

5.2

1.8

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

657

0.75

1.67

1.2

—

292.3

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

160

874

1.23

1.67

1.3

1.4

272.2

259.3

ug/g

0.34

541

(3019977) pH of Arterial blood

214

1.47

1.66

1.8

2.3

7.4

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

166

1337

0.82

1.66

1.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

409

0.68

1.66

1.2

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

724

0.76

1.66

1.3

1.4

1.1

1.2

g/l

0.28

674

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

242

1379

1.18

1.62

1.9

2.4

1.3

1.4

g/l

0.07

174

1144

(3036603) Volume of Urine

237

0.59

1.61

3.1

1.6

1462.6

1834.9

—

(3045424) Erythrocytes [Presence] in Urine

484

0.71

1.61

1.7

1.4

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

209

1178

1.19

1.59

2.0

2.2

0.0

0.1

g/l

0.94

164

1059

(3004616) Nuclear Ab [Presence] in Serum

301

0.64

1.58

1.1

1.3

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

3.71

1.56

1.0

—

(1761482) Bacteria [#/volume] in Urine by Culture

176

1400

0.83

1.56

4.9

4.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

332

0.66

1.56

1.1

1.0

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

1.55

0.0

1.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

175

0.53

1.55

1.1

1.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

269

2065

0.86

1.55

1.3

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

234

0.60

1.55

1.1

1.4

2.7

2.9

g/l

0.14

153

(4062490)

234

0.60

1.55

1.1

1.5

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

234

0.60

1.55

1.1

1.4

6.8

7.2

g/l

0.20

152

(3024139) IgG subclass 3 [Mass/volume] in Serum

234

0.60

1.55

1.1

1.4

0.6

0.4

g/l

0.67

153

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

302

1.37

1.55

1.3

1.2

235.6

582.5

titre

—

(3023419) Bacteria identified in Sputum by Culture

457

0.71

1.54

1.8

2.5

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.75

1.53

1.3

1.0

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

479

0.72

1.52

1.3

—

(3000494) Fungus identified in Specimen by Culture

453

3352

0.89

1.49

1.4

—

(3023420) DNA double strand Ab [Units/volume] in Serum

231

0.60

1.48

1.1

1.3

—

35.7

—

(3028626) Oxygen [Partial pressure] in Capillary blood

145

796

1.22

1.48

2.4

2.8

7.4

7.7

kpa

1.02

138

738

(3007566) Smooth muscle Ab [Titer] in Serum

596

0.76

1.45

1.1

80.0

182.7

titre

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

3.34

1.44

1.0

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

610

0.76

1.43

2.7

2.8

—

(3007164) IgA [Mass/volume] in Serum or Plasma

621

4510

0.91

1.43

1.4

1.5

2.8

2.7

g/l

0.32

271

2354

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

707

0.78

1.43

1.3

1.4

0.2

g/l

0.00

659

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

0.41

1.41

7.6

8.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.31

1.40

1.1

1.0

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

294

2224

0.88

1.40

2.5

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.00

1.38

0.0

1.0

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

197

1121

1.18

1.38

2.0

2.2

0.0

g/l

0.00

154

1007

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

291

0.66

1.38

1.2

1.4

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

291

0.66

1.38

1.2

1.4

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

291

0.66

1.38

1.2

1.4

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

407

0.72

1.35

1.5

75.7

62.7

1.97

258

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

648

0.78

1.33

1.2

41.6

46.5

u/l

0.14

545

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

359

0.70

1.33

1.1

1.2

54.0

68.2

u/l

0.79

239

(3000764) Benzodiazepines [Presence] in Urine

2.43

1.31

1.0

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

127

1.52

1.28

1.8

2.9

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

490

1.26

1.27

1.9

2.0

38.5

27.5

mg/l

0.64

102

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

798

0.81

1.27

2.1

2.4

1.7

1.8

mg/l

0.47

690

(3028300) Cannabinoids [Presence] in Urine

2.32

1.26

1.0

1.2

—

(3027008) Opiates [Presence] in Urine

2.32

1.26

1.0

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

332

0.70

1.26

1.2

1.3

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

188

0.60

1.26

3.1

1.7

13.8

16.6

—

(3022689) Creatine [Moles/volume] in Urine

0.48

1.24

1.3

1.5

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.50

1.24

1.0

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

475

0.76

1.22

1.3

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

245

1434

1.14

1.22

2.4

3.3

4.3

4.4

pmol/l

0.16

195

1250

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

437

0.75

1.22

1.3

1.1

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

1.58

1.20

1.3

1.6

81.9

58.8

5.34

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

104

0.51

1.17

4.5

1.7

—

(3047189) Immunofixation for 24 hour Urine

200

0.63

1.16

1.1

1.6

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

357

0.73

1.16

1.2

117.8

143.2

u/ml

—

(3011648) Oxygen content in Venous blood

224

0.65

1.16

1.1

1.6

8.8

10.6

0.96

224

(44813793)

124

0.54

1.14

1.0

1.1

—

(3023520) Reticulocytes [#/volume] in Blood

610

3771

1.09

1.13

2.3

2.5

66.4

66.3

e9/l

0.04

449

2846

(3027273) Bicarbonate [Moles/volume] in Venous blood

324

1942

1.12

1.13

2.7

3.1

25.2

24.9

mmol/l

0.87

317

1891

(3011985) Renin [Units/volume] in Plasma

347

0.73

1.12

1.2

1.5

36.5

53.1

mu/l

0.43

312

(3019225) pH of Specimen

610

3773

1.09

1.12

4.0

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

380

2299

1.11

1.12

2.5

3.0

127.0

124.9

g/l

1.13

373

2245

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

191

1107

1.15

1.11

2.0

2.2

0.0

g/l

0.00

154

1006

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

1.65

1.10

1.1

1.0

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

571

0.79

1.10

1.2

1.3

—

(3010375) cycloSPORINE [Mass/volume] in Blood

0.48

1.08

22.7

26.4

85.5

100.2

ug/l

—

(3016879) Cocaine [Presence] in Urine

2.22

1.08

1.0

1.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

480

0.78

1.08

1.8

1.5

1.3

3.3

mg/l

2.86

356

(4211845)

195

0.65

1.06

3.1

3.8

—

(40760888) Immunoglobulin light chains.free panel - Serum

147

1140

0.86

1.06

3.0

3.6

—

(3020393) Adenovirus Ag [Presence] in Stool

2.00

1.05

1.1

1.0

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

2.38

1.04

1.6

1.0

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

274

1637

1.12

1.03

1.9

2.2

7.6

g/l

0.02

168

1193

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

274

1637

1.12

1.03

1.9

2.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

161

0.62

1.02

1.0

1.1

—

(3045414) Leukocytes [Presence] in Urine

182

1385

0.87

1.02

2.3

2.0

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

273

1633

1.12

1.01

1.9

2.2

4.0

3.8

g/l

0.63

164

1139

(3043410) Blood group antigens tested for on Red Blood Cells

107

0.56

1.01

1.8

1.5

—

(3002523) Influenza virus A Ag [Presence] in Specimen

1.60

1.01

1.1

1.0

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

260

1551

1.12

1.01

1.9

2.2

10.6

10.5

g/l

0.05

187

1277

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.00

1.01

0.0

1.3

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

0.00

1.01

0.0

1.7

—

1.4

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.98

0.0

4.8

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

323

0.74

0.98

1.1

1.3

228.7

261.5

pmol/l

0.47

250

(3044941) Cell count panel - Synovial fluid

526

1.21

0.98

1.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

375

0.76

0.97

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.82

0.96

1.7

1.8

51.1

46.6

umol/l

—

(21494890) Protein electrophoresis panel - 24 hour Urine

449

0.79

0.96

1.7

2.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

411

0.78

0.94

1.1

1.3

—

(3035637) Corticotropin [Mass/volume] in Plasma

313

0.74

0.94

1.1

1.6

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

181

0.66

0.94

3.1

1.8

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

305

0.74

0.94

1.1

—

u/ml

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

116

0.57

0.94

1.0

1.1

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

250

1497

1.12

0.93

2.0

2.2

3.2

g/l

0.02

165

1162

(3034860) Kappa light chains.free [Mass/volume] in Serum

202

1515

0.89

0.93

2.7

3.4

54.0

100.1

mg/l

0.64

160

1225

(3024263) Appearance of Synovial fluid

172

1.36

0.92

1.5

1.7

—

(3000034) Microalbumin [Mass/volume] in Urine

319

0.75

0.92

2.4

3.0

40.3

24.1

mg/l

0.40

232

(3041096) Erythrocytes [Presence] in Urine by Automated

1263

8071

1.05

0.90

4.6

3.8

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4992

33688

0.96

0.89

9.4

10.9

22.2

22.9

u/l

0.90

4616

31747

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2120

13717

1.04

0.89

4.7

6.2

8.1

4.7

ug/l

0.63

1792

12035

(3003740) Influenza virus B Ag [Presence] in Specimen

1.54

0.88

1.1

1.0

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

516

0.81

0.87

1.2

1.3

—

(3004775) Volume in Urine collected for unspecified duration

353

0.77

0.86

2.4

2.1

734.0

659.3

0.42

231

(3017143) Hepatitis C virus Ab [Presence] in Serum

267

1961

0.90

0.86

1.3

1.4

—

(3044927) Protein electrophoresis panel - Urine

400

1.22

0.86

1.3

1.2

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

0.57

0.85

1.0

1.5

0.9

g/l

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

397

0.79

0.85

1.1

1.3

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

324

1978

1.10

0.85

4.1

7.3

24.1

24.3

mmol/l

0.32

286

1824

(3023487) Leukocytes [#/volume] in Peritoneal fluid

145

0.64

0.85

1.3

1.5

782.9

1481.9

e6/l

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

404

0.79

0.85

1.1

1.3

—

(3035320) C reactive protein [Mass/volume] in Body fluid

246

0.73

0.84

2.9

2.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

135

1031

0.87

0.84

2.0

1.8

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

396

0.79

0.84

1.1

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

396

0.79

0.84

1.1

1.3

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

168

0.67

0.83

1.1

1.4

3.0

4.7

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

136

0.64

0.83

1.3

1.4

1319.6

19402.0

e6/l

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

395

0.79

0.82

1.1

1.3

—

(44806071)

1.91

0.81

1.3

1.1

—

(40758358) Immune stain study

0.00

0.81

0.0

1.0

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.00

0.81

0.0

2.6

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

0.50

0.80

1.0

1.3

—

212.5

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.49

0.79

1.0

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

378

0.79

1.2

100.4

44.5

u/ml

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

204

1510

0.90

0.78

2.6

3.4

50.0

54.6

mg/l

0.15

165

1228

(3022493) Free Hemoglobin [Mass/volume] in Plasma

121

1.38

0.75

1.0

2.4

61.7

64.0

mg/l

0.08

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

0.54

0.74

1.0

—

1.5

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

462

0.82

0.74

1.5

1.4

—

(40768446) Kidney Pathology biopsy report

0.53

0.74

1.0

1.5

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

217

0.74

1.5

4.9

7.6

u/l

0.64

106

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

548

0.84

0.73

1.3

348.5

449.8

u/l

0.50

530

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

216

0.74

0.72

1.3

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

216

0.74

0.72

1.3

1.5

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

276

2001

0.92

0.72

4.6

7.5

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

331

1.21

0.70

2.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

267

0.77

0.69

1.2

1.1

—

(3048879) Bone marrow aspiration report

153

0.70

0.69

1.1

1.5

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

326

0.80

0.69

1.5

13.4

29.7

4.49

209

(3027923) C peptide [Moles/volume] in Serum or Plasma

106

1.38

0.68

1.0

1.2

1.4

1.1

nmol/l

0.60

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.67

0.68

1.0

1.3

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

513

0.84

0.66

1.3

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

200

1463

0.91

0.65

2.7

3.3

2.2

4.7

ratio

0.74

113

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

219

0.76

0.64

1.4

1.5

58.9

68.0

0.54

175

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

0.58

0.64

3.8

3.0

—

(3015183) Erythrocyte sedimentation rate

0.58

0.64

1.0

1.7

—

(3016750) Collection duration of Urine

241

0.77

0.63

2.5

1.9

510.3

499.9

min

0.38

178

(3037556) Urate [Mass/volume] in Serum or Plasma

111

0.66

0.63

1.4

1.5

—

(3012565) Volume of 24 hour Urine

165

0.73

0.62

2.1

1675.0

1810.1

0.17

136

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

0.62

0.0

1.5

—

355.7

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

0.62

0.0

2.8

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.62

0.0

10.9

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.62

0.0

1.0

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

134

0.70

0.62

1.1

1.0

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

530

0.85

0.61

1.2

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

100

757

0.88

0.60

1.5

49.9

4.7

iu/ml

0.80

209

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

260

1604

1.08

0.60

3.5

4.1

1.6

1.5

0.58

251

1505

(3027944) Amphetamines [Presence] in Urine

1.82

0.60

1.0

1.2

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

711

4534

1.05

0.60

3.4

4.8

1.0

mmol/l

1.87

614

4115

(4146454)

421

0.84

0.59

2.5

2.7

—

(3000012) Reticulocyte production index

275

0.80

0.59

1.4

1.5

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

215

0.77

0.58

1.1

—

(3014051) Protein [Presence] in Urine by Test strip

107

802

0.89

0.57

2.7

2.3

—

(3036782) Glucose [Moles/volume] in Pleural fluid

518

0.86

0.56

1.3

1.4

6.4

6.2

mmol/l

0.15

486

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

309

0.82

0.55

1.2

1.3

—

nmol/l

—

(3051101) Glucose [Moles/volume] in Cord blood

107

0.68

0.54

6.5

5.5

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

212

0.79

0.53

1.1

1.3

110.0

94.2

titre

—

(3002619) Bacteria identified in Specimen by Culture

0.59

0.53

1.5

1.3

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

1.42

0.51

1.4

1.5

16.6

17.1

pmol/l

—

(3017732) Neutrophils [#/volume] in Blood

267

1904

0.93

0.51

3.2

3.0

4.2

4.4

e9/l

0.30

159

1285

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

437

1.15

0.51

5.3

5.7

12.9

12.4

mg/l

0.42

397

(3014148) Varicella zoster virus Ab [Titer] in Serum

105

0.70

0.50

1.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

0.63

0.49

5.1

2.8

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

0.69

0.49

1.9

1.6

9.9

10.7

ug/l

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.56

0.49

1.6

1.0

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

103

765

0.90

0.49

1.3

1.4

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

112

0.71

0.49

1.1

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

125

918

0.91

0.48

1.4

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1.39

0.48

1.1

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

216

0.80

0.48

1.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

602

0.88

0.48

1.4

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

119

0.73

0.47

2.5

1.8

960.1

1847.8

u/ml

1.42

119

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

252

0.82

0.47

1.6

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.46

0.47

1.0

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

122

894

0.91

0.46

1.9

1.6

—

(3022096) Basophils/100 leukocytes in Blood

2121

14402

0.97

0.46

4.6

5.7

0.6

2.30

1901

13192

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.41

0.45

1.6

1.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

157

1.23

0.45

1.0

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

192

0.80

0.45

1.5

1.4

3.7

1.8

0.36

151

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

443

0.87

0.44

1.2

1.3

24.5

12.4

u/l

0.94

415

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

228

0.82

0.44

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.67

0.44

1.2

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.67

0.44

1.2

10.2

11.0

u/l

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

1.40

0.43

1.2

1.1

—

29.9

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

0.00

0.42

0.0

8.1

—

20.1

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.42

0.0

1.0

—

(3019174) dRVVT (LA screen)

0.00

0.42

0.0

1.5

—

(3003434) Protein [Mass/volume] in Pleural fluid

110

805

0.91

0.42

1.4

1.5

30.1

31.8

g/l

0.85

717

(3007930) Methemoglobin/Hemoglobin.total in Blood

254

1595

1.06

0.41

3.4

4.1

0.9

1.38

246

1493

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

110

804

0.91

0.41

1.3

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

141

1.23

0.41

1.0

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

141

1.23

0.41

1.0

1.4

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

123

0.76

0.41

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

123

0.76

0.41

1.0

—

(3037121) Protein [Mass/volume] in Urine

198

1234

1.07

0.41

2.3

3.0

0.3

g/l

0.01

517

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

0.66

0.40

1.4

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

152

0.79

0.40

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

152

0.79

0.40

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

152

0.79

0.40

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

152

0.79

0.40

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

152

0.79

0.40

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

152

0.79

0.40

1.1

—

(40761536) Microorganisms panel - Urine sediment

424

2952

0.95

0.39

5.0

3.9

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

360

0.87

0.39

1.2

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1232

8406

0.97

0.39

2.3

2.5

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

144

0.79

0.38

1.1

1.3

—

(3020491) Glucose [Moles/volume] in Blood

216

1.17

0.38

2.0

2.8

6.5

7.4

mmol/l

2.00

149

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

309

0.86

0.37

1.2

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.38

0.37

1.1

1.0

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

259

0.85

0.37

1.3

1.4

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.30

0.37

1.0

1.3

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

143

0.79

0.37

1.1

1.3

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

172

0.81

0.36

1.0

1.1

13.8

12.3

mmol/l

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

161

1002

1.07

0.36

1.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

149

1066

0.93

0.36

1.7

1.6

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

272

0.86

0.36

1.2

1.1

—

(4015189)

0.71

0.36

1.3

2.6

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1345

8786

1.03

0.35

2.6

3.1

34.5

38.2

u/l

0.76

1224

8225

(3017704) Immunofixation for Urine

231

1.16

0.34

1.5

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

271

0.86

0.34

1.3

1.5

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1.33

0.34

1.8

2.0

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

1.33

0.34

2.2

2.1

0.2

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

0.72

0.31

1.3

3.0

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

336

2149

1.04

0.31

1.2

1.3

—

(3002385) Erythrocyte distribution width [Ratio]

3796

25518

0.98

0.31

25.0

19.8

14.0

2.02

3673

24770

(4212803)

1.33

0.31

1.2

1.0

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.30

0.30

12.4

9.7

—

(3006504) Eosinophils/100 leukocytes in Blood

2188

14779

0.98

0.30

4.6

5.6

2.8

0.04

1961

13507

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

116

1.21

0.30

1.1

1.0

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

210

0.86

0.29

1.0

1.1

116.3

115.7

0.05

173

(3019069) Monocytes/100 leukocytes in Blood

2200

14851

0.98

0.29

4.8

5.9

8.9

9.0

0.82

1974

13621

(3029075) Extractable nuclear Ab panel - Serum

1.31

0.28

1.2

1.0

—

(4306422)

216

0.86

0.28

1.3

1.2

—

(3044889) 12 lead EKG panel

3567

23973

0.98

0.28

4.6

4.3

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

312

1.11

0.28

1.4

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

166

0.84

0.28

1.2

1.4

—

(3019198) Lymphocytes [#/volume] in Blood

2403

15842

1.02

0.27

4.6

5.5

1.8

1.9

e9/l

1.16

1980

13412

(3032773) Endomysium IgG Ab [Titer] in Serum

180

1.15

0.27

1.0

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

100

0.80

0.26

2.1

2.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

0.73

0.24

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

0.73

0.24

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

0.73

0.24

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

0.73

0.24

1.0

1.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

192

0.87

0.24

1.2

105.4

97.5

u/l

0.10

165

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

213

0.88

0.24

1.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

213

0.88

0.24

1.4

—

(3026470) Cobalt [Mass/volume] in Blood

290

0.90

0.24

1.9

2.7

3.8

ug/l

0.46

258

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

113

709

1.06

0.24

1.5

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

338

0.91

0.23

1.0

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

2771

18637

0.99

0.23

5.9

9.0

4.8

4.3

e9/l

10.72

2326

15919

(3035880) pH of Pleural fluid

317

0.90

0.23

1.2

1.3

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

326

2103

1.04

0.23

1.5

1.6

g/l

0.09

246

1786

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

813

5315

1.02

0.23

2.2

2.4

19.7

21.3

2.88

617

4548

(3028433) Virus identified in Specimen by Culture

0.81

0.23

1.1

1.2

—

(4268621)

155

0.86

0.22

1.9

2.2

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.22

0.0

1.0

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.22

0.0

1.1

—

70.8

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.22

0.0

1.0

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.22

0.0

12.4

—

(3047185) IgG [Mass/volume] in Urine

0.00

0.22

0.0

1.4

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.22

0.0

1.0

—

8.1

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.22

0.0

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.22

0.0

1.0

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

660

0.94

0.22

1.2

1.3

—

(3044007) Cell count panel - Peritoneal fluid

112

0.83

0.22

1.5

1.4

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

0.75

0.21

1.3

148.8

115.3

ng/l

—

(36660697) Celiac disease serology panel - Serum

275

1772

1.04

0.21

1.2

—

(3044009) aPTT.lupus sensitive (LA screen)

0.00

0.21

0.0

1.4

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

0.21

0.0

1.4

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

0.21

0.0

10.2

—

27.2

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.21

0.0

1.0

—

(40762887) Creatinine [Moles/volume] in Blood

0.00

0.21

0.0

1.3

—

(3020779) Urea [Moles/volume] in Serum or Plasma

490

3347

0.97

0.21

3.8

5.5

11.5

11.9

mmol/l

0.57

446

3123

(44816559) Phosphatidylethanol [Mass/volume] in Blood

238

0.90

0.21

1.1

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

224

0.89

0.21

1.5

1.2

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

861

5642

1.02

0.20

2.1

2.4

2.1

2.2

g/l

5.67

749

5200

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.78

0.20

1.2

1.4

—

(4024509)

332

1.09

0.20

1.4

1.7

—

(3018010) Neutrophils/100 leukocytes in Blood

2198

14790

0.99

0.20

4.6

5.6

61.1

59.1

10.71

1980

13543

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

758

4963

1.02

0.20

1.2

1.5

2.2

u/ml

0.93

150

1127

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

160

0.87

0.19

1.0

—

(44786800) Granulocytes/100 leukocytes in Body fluid

1.20

0.19

1.4

1.3

22.9

24.4

—

(3021788) Differential panel - Synovial fluid

622

0.94

0.19

1.5

1.4

—

(3044640) Blood type and Crossmatch panel - Blood

1649

11115

0.99

0.19

2.3

2.5

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

278

0.91

0.19

1.2

1.5

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

359

1.08

0.19

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

0.83

0.19

1.2

—

(3002030) Lymphocytes/100 leukocytes in Blood

2242

15077

0.99

0.18

4.8

5.8

23.4

25.5

14.48

1998

13726

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

215

0.90

0.18

2.0

1.7

—

(3000475) Leukocytes [#/volume] in Synovial fluid

125

796

1.05

0.18

1.6

28883.6

12870.9

e6/l

1.08

561

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

0.72

0.17

1.6

1.3

—

(3013727) Leukocytes other/100 leukocytes in Blood

137

0.88

0.17

2.8

3.5

53.1

54.5

0.09

129

(3019897) Erythrocyte distribution width [Ratio] by Automated count

1.16

0.16

10.8

7.8

14.0

13.8

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

1.16

0.16

1.1

1.2

27.2

31.1

g/l

0.51

(42870588) Differential panel, method unspecified - Blood

1687

11142

1.01

0.16

4.1

5.5

—

(3020650) Glucose [Presence] in Urine

1.11

0.16

3.1

1.5

—

(44806118)

323

0.93

0.16

1.2

1.3

—

(44790047)

323

0.93

0.16

1.2

1.3

—

(44790048)

323

0.93

0.16

1.2

1.3

—

(44790049)

323

0.93

0.16

1.2

1.3

—

(3013115) Eosinophils [#/volume] in Blood

2421

16029

1.01

0.15

4.5

5.5

0.2

e9/l

0.01

1974

13517

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

247

0.92

0.15

1.1

1.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1.09

0.15

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

0.78

0.15

1.0

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

170

0.90

0.14

1.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

503

3295

1.02

0.14

3.4

3.7

1.2

mmol/l

0.06

392

2783

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

0.82

0.14

1.0

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1667

11027

1.01

0.13

4.4

5.2

21.4

22.5

2.12

833

6510

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

162

0.91

0.13

1.0

1.1

95.7

92.7

0.24

143

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

1.19

0.13

4.3

1.7

179.4

206.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

601

1.04

0.13

3.0

2.4

—

(3003327) Ova and parasites identified in Stool by Light microscopy

660

0.96

0.13

1.5

1.7

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

189

0.92

0.12

1.2

37.5

29.1

u/l

0.26

158

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

0.85

0.12

1.0

1.3

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.16

0.12

1.1

—

(3049717) Cytology report of Urine Cyto stain

284

1856

1.02

0.11

2.7

3.1

—

(3037756) Immunofixation for Serum or Plasma

147

952

1.03

0.11

1.5

1.6

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1.14

0.10

1.3

1.1

—

(3048689) Calprotectin [Mass/mass] in Stool

370

2506

0.98

0.10

1.8

1.9

172.4

160.0

ug/g

0.27

268

1893

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

228

0.94

0.10

1.0

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

304

1.05

0.10

1.3

1.5

154617.0

130197.7

e6/l

0.07

221

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

488

1.04

0.09

1.4

—

(3025549) Creatine [Moles/time] in 24 hour Urine

1.04

0.09

1.4

1.3

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

103

1.10

0.09

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.08

0.09

1.2

1.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

308

0.95

0.08

1.7

1.3

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.13

0.08

1.1

1.0

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

404

1.04

0.08

1.4

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

117

0.91

0.08

2.1

2.5

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.81

0.08

1.0

—

(3001604) Monocytes [#/volume] in Blood

2333

15490

1.01

0.08

4.4

5.3

0.6

e9/l

0.17

1917

12843

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

253

0.95

0.08

1.1

1.2

1.6

5.8

u/ml

—

(3026389) Candida sp identified in Specimen by Organism specific culture

372

1.04

0.08

1.3

1.4

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

530

0.97

0.08

1.2

—

(3034426) Prothrombin time (PT)

0.80

0.07

1.0

1.3

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1.10

0.07

1.1

1.2

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

117

1.08

0.07

1.2

1.4

18.8

20.4

0.09

(3033799) Differential panel - Peritoneal fluid

123

0.92

0.07

1.4

1.7

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

0.85

0.07

1.6

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.07

0.07

1.4

1.5

—

(3025577) Chromium [Mass/volume] in Blood

279

0.96

0.07

1.9

2.0

1.7

2.1

ug/l

0.32

240

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

1.13

0.07

1.1

1.2

17.4

15.7

u/l

—

(40757494) Bilirubin.total [Moles/volume] in Blood

177

0.94

0.07

1.7

1.9

19.1

19.7

umol/l

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

439

0.97

0.05

1.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

646

1.02

0.05

1.4

1.5

24607.6

44434.3

e6/l

1.39

359

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

196

0.95

0.05

1.6

3.3

—

(3045788) Cell count panel - Pleural fluid

552

0.98

0.05

1.6

1.5

—

(3012441) Differential panel - Pleural fluid

615

1.02

0.04

1.5

—

(3004451) EKG impression Narrative

181

0.96

0.04

1.1

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

241

0.97

0.03

1.1

1.2

7.0

4.2

u/ml

0.37

103

(3017569) Oxygen content in Arterial blood

180

1.04

0.03

1.9

2.4

—

(3036670) Protein [Mass/volume] in Synovial fluid

126

0.95

0.02

1.2

40.0

37.8

g/l

0.42

(40768806) Pleura Pathology biopsy report

615

0.99

0.02

1.5

1.6

—

(3042936) Bacteria identified in Isolate by Culture

714

4745

1.00

0.02

1.9

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

0.93

0.02

5.1

1.7

156.6

187.0

—

(3006315) Basophils [#/volume] in Blood

2344

15607

1.00

0.02

4.4

5.3

0.0

e9/l

1.68

1929

12945

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

614

0.99

0.02

1.4

1.6

2.8

5.4

iu/l

2.56

190

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

105

0.95

0.01

1.1

1.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

138

927

0.99

0.01

2.1

2.3

104.4

102.2

ug/min

0.02

522

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

419

0.99

0.01

3.0

3.7

—

(3023383) Lactate [Moles/volume] in Pleural fluid

162

1.03

0.01

1.2

1.3

4.8

2.8

mmol/l

1.62

149

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

104

0.96

0.00

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

104

0.96

0.00

1.1

1.2

4.9

15.9

umol/l

—

(21491868) Cryoglobulin [Mass/volume] in Serum

0.98

0.00

1.2

1.1

—

0.1

g/l

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

0.99

0.00

1.0

1.1

—

(40762814) Titanium [Mass/volume] in Blood

0.99

0.00

2.3

2.2

2.9

3.8

ug/l

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

254

1.00

0.00

1.0

1.1

—

24.3

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

319

1.00

0.00

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

105

702

1.00

0.00

1.4

1.5

3776.9

1520.9

e6/l

0.65

484

(3001019) Free T4 and TSH panel - Serum or Plasma

203

0.99

0.00

1.6

1.8

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

162

0.99

0.00

1.3

984.1

130.2

ug/l

0.47

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

113

1.00

0.00

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.0

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.0

6.5

—

412.2

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

0.0

1.5

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

0.00

0.0

1.0

—

5.3

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.0

1.0

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

0.93

0.00

1.0

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

3.2

—

(3013862) HLA-DP [Type]

0.00

0.0

1.0

—

(36303858) Crystals [Presence] in Urine

0.00

0.0

1.0

—

(3016135) IgD [Mass/volume] in Serum

0.00

0.0

1.0

—

39.6

—

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

0.00

0.0

15.6

—

34.8

—

(3013762) Body weight Measured

0.00

0.0

1.0

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

0.00

0.0

1.2

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

1.5

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

0.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.00

0.0

1.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

0.99

0.00

1.0

1.4

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.93

0.00

1.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.01

0.00

4.4

5.4

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

0.97

0.00

1.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.0

1.0

—

(3001729) Color of Synovial fluid

1.00

0.00

2.3

1.8

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.94

0.00

1.6

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

0.95

0.00

1.2

1.4

8.5

9.6

ug/l

—

(3000285) Sodium [Moles/volume] in Blood

0.95

0.00

1.7

1.3

—

Mortality – FinRegistry

↥

Association

Association between endpoint AD_LO_EXMORE and mortality.

Females

Parameter	HR [95% CI]	p-value
AD_LO_EXMORE	2.157 [1.96, 2.37]	< 0.001
Birth year	0.991 [0.98, 1.0]	0.03

During the follow-up period (1.1.1998 — 31.12.2019), 51753 out of 77066 females with AD_LO_EXMORE died.

Males

Parameter	HR [95% CI]	p-value
AD_LO_EXMORE	2.456 [2.15, 2.8]	< 0.001
Birth year	0.984 [0.97, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 28916 out of 40995 males with AD_LO_EXMORE died.

Mortality risk

Mortality risk for people of age

years, who have AD_LO_EXMORE.

N-year risk	Females	Males
1	0.192%	0.398%
5	1.076%	2.257%
10	2.645%	5.951%
15	4.815%	10.915%
20	8.022%	18.077%

Relationships between endpoints

↥

Index endpoint: AD_LO_EXMORE – Alzheimer’s disease (Late onset), excluding more controls

GWS hits: 20

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Alzheimer’s disease (Late onset), excluding more controls

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints